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ABSTRACT 
NANOSECOND PULSED ELECTRIC FIELD INDUCTION OF PROGRAMMED 
CELL DEATH IS CELL TYPE DEPENDENT: AN IN VITRO STUDY 
Wei Ren 
Old Dominion University, 2011 
Co-Directors: Dr. Stephen J. Beebe 
Dr. R. James Swanson 
Nanosecond pulsed electric fields (nsPEFs) present a novel and effective method 
for cancer ablation by eradicating the ubiquitous cancer hallmark of apoptosis evasion 
and enforcing cancer programmed cell death. To develop nsPEFs as an anticancer 
method, a comprehensive understanding of cell death mechanisms is required. The 
overall objective of this dissertation is to elucidate molecular mechanisms underlying 
effects of nsPEFs on E4 murine squamous cell carcinoma and human T-cell Jurkat clones 
that are wildtype, deficient in FADD (AFADD) and deficient in caspase-8 (ACas-8). The 
overall hypothesis is that nsPEFs eliminate cancer cells through activating caspase-
dependent and caspase-independent programmed cell death pathways that originate from 
plasma membranes and/or intracellular membranes, especially mitochondria and 
endoplasmic reticulum. The specific aims are to: 1) determine whether nsPEFs induce 
cell death in E4 cells and Jurkat clones through caspase activation, 2) determine 
involvement of caspase-independent mechanisms in nsPEF-induced apoptosis in E4 cells 
and Jurkat clones and 3) determine signaling pathways for caspase-dependent apoptosis 
mediated by nsPEFs in E4 cells and Jurkat clones in vitro. Our findings are: 1) nsPEFs 
appear to induce apoptosis through the extrinsic pathway in E4 cells because caspase 
activation occurs before cytochrome c release. However, results from Jurkat clones, 
which have mutations in the extrinsic apoptosis pathway, suggest that apoptosis is 
induced by nsPEFs through the intrinsic pathway. 2) NsPEFs have rapid effects to 
decrease the mitochondria membrane potential and in Jurkat cells this occurs in the 
presence or absence of calcium or sodium. 3) NsPEFs activate calcium-dependent calpain 
pathways in E4 cells, which, in part, contribute to Bid cleavage, with calcium 
contributions from extracellular (70%) and intracellular (30%) compartments and 4) Cells 
respond to nsPEFs differently in terms of caspase-dependent apoptotic pathways 
depending on cell type. Apoptosis is induced through the intrinsic pathway in Jurkat 
cells, whereas in E4 cells, both intrinsic and extrinsic pathways are activated upon 
nsPEF-stimulation. These findings provide new insights into mechanisms by which 
nsPEFs promote cancer cell death, and demonstrate that nsPEFs administration can be 
utilized as a new therapeutic strategy for cancer ablation. 
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Maintenance of homeostasis and development of multicellular eukaryotic 
organisms require a delicate balance between cell division and cell death. Disturbance of 
this balance has been implicated in diseases such as cancer due to pathological cell 
accumulations. According to the nomenclature committee on cell death, four typical cell 
death modalities and eight atypical cell death modalities has been recognized. Among the 
best characterized modes of cell death are represented by apoptosis, autophagic cell 
death, necrosis, and cornification (1). Necrosis has been considered a passive form of cell 
death caused by catastrophic toxic or traumatic events. It is associated with swelling of 
the cell and its organelles, cell lysis, release of cytoplasmic constituents and resulting 
inflammation (2). Apoptosis, largely different from necrosis, is a genetically controlled 
process of cell suicide that plays an important role in cellular homeostasis by eliminating 
superfluous or damaged cells (3). Autophagic cell death is marked by the accumulation of 
double- or multiple- membrane autophagosomes in the cytoplasm of cells. Cornification 
represents the process of terminal keratinocyte differentiation, which allows the 
formation of corneocytes in the epidermis. It is a particular form of programmed cell 
death, morphologically and biochemically distinct from apoptosis (1). 
The model of the Journal of Biological Chemistry is used in this dissertatioa 
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Apoptosis is an evolutionaryy conserved suicide process that plays critical roles 
in embryonic development, homeostasis, remodeling, surveillance and atrophy of normal 
tissues (4). It can be induced in a vast array of ways such as nutrient exhaustion, ionizing 
radiation, serum removal, growth factor deficiency (5-7). Apoptosis is a complex cascade 
of events characterized by a series of morphological and biochemical alterations of the 
cell including phosphatidyl serine (PS) externalization, mitochondrial cytochrome c 
release, cell shrinkage, chromatin condensation, nucleosomal DNA fragmentation into 
multiples of 180bp, and the disruption of mitochondrial membrane potential resulting in 
plasma membrane blebbing and formation of apoptotic bodies. Finally, these apoptotic 
bodies are engulfed and digested by neighboring cells or macrophages (8, 9). Activation 
of caspases, a family of cysteine proteases, plays a central role in apoptosis. Apoptosis 
can also occur through caspase-independent pathways (10). 
Caspase 
Caspases, or cysteine-aspartic proteases, are a family of cysteine proteases that 
cleave substrates after aspartic acid residues. Caspases both initiate and execute cell 
disassembly in response to pro-apoptotic signals. To date at least 14 distinct mammalian 
caspases have been described in species ranging from the nematode to the dipteran 
Drosophila melanogaster and the lepidopteran Spodoptera frugiperda (11). At least 8 of 
the 14 caspases are involved in apoptosis and they are classified into two groups, the 
initiator caspases, which include caspases-2, -8, -9 and -10, and executioner caspases, 
which include caspases-3, -6, and -7. 
All apoptotic caspases are present as inactive zymogens (pro-caspases) in cells 
containing an N-terminal prodomain and a C-terminal catalytic domain consisting of ~20 
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kD (p20) and -10 kD (plO) subdomains, and must undergo proteolytic cleavage to be 
converted to activate forms during apoptosis (11). For all caspases, the main structures of 
C-terminal domains share high sequence homology, while their N-terminal prodomains 
differ dramatically. The initiator caspases usually contain large N-terminal domains, such 
as the caspase recruitment domain (CARD) in caspase-2, -9, or a pair of death effecter 
domains (DEDs) in caspase-8 and -10. These domains consist of specific protein-protein 
interaction motifs that play crucial roles in the activation process (12). 
Caspases are activated either by a ligand binding to death receptors that leads to 
rapid induction of initiator caspases or by stimuli that release cytochrome c and apoptosis 
inducing factors (AIF) from mitochondria. Upon apoptotic stimulation, the pro-caspase 
are recruited by virtue of their N-terminal prodomain to specific death signaling 
complexes and subsequently undergo self activation by "induced-proximity" mechanism 
(13). In contrast, the executioner caspases only have short N-terminal domains and thus is 
not capable of undergoing self activation in vivo. Their activation depends on the 
cleavage of initiator caspases. The activating cleavage of executioner caspases is taken 
place at specific internal Asp residues located in small linker regions between the 
prodomain, p20, and plO subunits by an initiator caspase (11). This separation of the 
large and small subunits allows two p20 and two plO subunits to resemble noncovalently 
into the active executioner caspase. 
Once activated, the executioner caspases cleave a broad range of cellular targets 
and ultimately destruct the cell. The known cellular substrates include structural 
components (such as actin and nuclear lamin), poly (ADP-ribose) polymerase (PARP), 
inhibitors of deoxyribonuclease (such as DFF45 or ICAD), and other pro-apoptotic 
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proteins and caspases. Cleavage of the DFF45 (DNA fragmentation factor 45) leads to 
removal of its inhibition of DFF45 or CAD (caspases-activated deoxyribonuclease), 
which degrades the chromosomes into nucleosomal fragments during apoptosis (14). 
Apoptosis pathways 
Extrinsic pathway 
Apoptosis can be mediated through the extrinsic pathway or the intrinsic pathway 
depending on the cell type and the origin of the death stimuli. The extrinsic pathway is 
initiated by the recruitment of the tumor necrosis factor (TNF) receptor super-family such 
as CD95 (APO-1/Fas) or TNF-related apoptosis-inducing ligand (TRAIL) receptors and 
specific death ligands, which then assemble the death-inducing signaling complex 
(DISC) and leads to proteolytic cleavage and activation of caspase-8. In type I cells, 
caspase 8 directly cleaves downstream executioner caspase-3, -6, and -7 and mediates 
cell death. Whereas in type II pathways, caspase-8 cleaves the BH3 domain-containing 
pro-apoptotic protein Bid. Translocation of truncated form of Bid in collaboration with 
Bax or Bak triggers the release of pro-apoptotic proteins from the mitochondrial 
intermembrane space, including cytochrome c, apoptosis-inducing factor (AIF), and 
second mitochondrial-derived activator of caspase (Smac/DIABLO). Once cytochrome c 
is released into cytosol, it interacts with apoptotic protease-activating factor-1 (Apaf-1) 
and enables the assembly of the apoptosome, in which caspase-9 is autoproteolytically 
activated. Caspase-9 then activates executioner caspase-3, -6, -7, and promotes further 
activation of the initiator caspase-8 and -10 as a positive feedback loop in the extrinsic 
pathway (15). Smac/DIABLO activates caspase-9 and -3 by neutralizing the inhibitory 
effect of IAP (inhibitors of apoptosis proteins) through physical interactions (16, 17). 
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Death receptor 
The most direct pathway connecting death-promoting signals to apoptotic cell 
demise to be mediated by the death receptors, such as the type 1 tumor necrosis factor a 
(TNFa) receptor TNF-R1 (CD 120a), CD95 (Fas/APO-1), DR3 (TRAMP/wsl/APO-3), 
TRAIL-R1 (DR4), TRAIL-R2 (DR5), a subgroup of the TNF-R superfamily, and their 
cognate death ligands TNFa, CD95 ligand (FasL), Apo3L and TRAIL (APO-2L), 
respectively (18-21). Binding of a ligand to its cell-surface death receptor facilitates 
receptor aggregation and recruitment of pro-apoptotic adaptor molecules such as TRADD 
(Tumor necrosis factor receptor type 1-associated DEATH domain protein) and FADD 
(Fas-associated via death domain) through homotypic interactions between death 
domains (DD) in each of the protein (22). In turn, adaptors associated with caspase-8 
(FLICE) through the death-effector domains (DED) in a homotypic manner resulting in 
the formation of a DISC (23). Within the complex, caspase-8 is dimerization and 
proteolytically activated. This in turn activates terminal executioner caspases either via 
direct activation of executioner caspases (type I cells) or through activation of the 
mitochondrial pro-apoptotic machinery (type II cells) (24). Inhibition of death receptor-
induced apoptosis may occur at the DISC level resulting from binding of FLIPs (FLICE-
inhibitory proteins) to FADD or mitochondrial level due to high levels of Bcl-2 or Bcl-xl 
(25). 
Intrinsic pathway 
The intrinsic pathway is activated by a wide range of internal stresses, such as 
oxidative stress, DNA double strand break, misfolded protein in endoplasmic reticulum 
and oncogenes activation. All of these stimuli cause changes in the inner mitochondrial 
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membrane that result in an opening of the mitochondrial permeability transition pore 
(mPTP), loss of the mitochondrial transmembrane potential and release of two main 
groups of pro-apoptotic proteins from the intermembrane space into the cytosol (26). The 
first group of well-characterized proteins include cytochrome c, Smac/DIABLO, and 
HtrA2/Omi (17, 27). These proteins trigger apoptosis through the caspases-dependent 
mitochondrial pathway. Cytochrome c binds to Apaf-1 (apoptotic protease-activating 
factor 1), inducing Apaf-1 to undergo a nucleotide d ATP-dependent conformational 
change which forms a multiprotein caspases-activating complex, "apoptosome" and 
facilitates binding of pro-caspase 9 through N-terminal CARD domains present in both 
molecules (28). As a result of this binding, pro-caspase 9 is activated. Smac/DIABLO 
and HtrA2/Omi are reported to block caspse inhibitory activity of IAP (inhibitors of 
apoptosis proteins) (16, 17). The cleavage of their mitochondrial-targeting sequences 
generates the IAP-binding motif, which contains a conserved short stretch of hydrophobic 
amino acids, AVPI or AVPS, in Smac and Omi, respectively. This motif is exposed upon 
release into the cytosol leading to Smac and Omi binds to the BIR domains of IAP and 
hence the BIR-bound caspases are released and reactivated (29). 
It has now been recognized that the second group of pro-apoptotic factors released 
from the mitochondria during apoptosis consists of AIF, EndoG (endonuclease G), that 
are involved in caspases-independent cell death (30, 31). AIF translocates to the nucleus 
and subsequently initiates a type of peripheral nuclear chromatin condensation and large-
scale (50kb) DNA fragmentation (32). It has been reported that, in mammalian cells, 
EndoG also translocates to the nucleus during apoptosis where it induces 
oligonucleosomal DNA fragmentation independent of caspases (33). Moreover, 
7 
subsequent studies have demonstrated that EndoG can cooperate with exonuclease and 
DNase and facilitate both high molecular weight DNA cleavage and oligonucleosomal 
DNA breakdown in a sequential fashion. 
Bcl-2 family and cytochrome c release 
Bcl-2 family proteins and play a pivotal role in controlling and regulating these 
apoptotic mitochondrial events through governing the permeability of the outer 
mitochondrial membrane (34). To date, at least 20 Bcl-2 family members have been 
identified in mammalian cells and viruses, exhibiting either proapoptotic or antiapoptotic 
properties (35). Bcl-2 and Bcl-xl are antiapoptotic members. They protect cells against 
apoptosis by inhibiting the function of the pro-apoptotic Bcl-2 proteins. The cleavage of 
Bcl-2 and Bcl-xl by caspases reinforces cytochrome c release from the mitochondria (36). 
The proapoptotic members can be divided into two subfamilies based on structure 
discrepancies. Bax and Bak share three BH domains and lack the BH4 domain. The 
proapoptotic protein Bax is localized in the cytosol and translocates to mitochondria upon 
apoptotic stimulation (37). Unlike Bax, Bak constitutively resides on mitochondria and 
homo-oligomerizes during apoptosis (38). In the mitochondrial outer membrane, the 
proapoptotic functions of Bak and the related Bax protein depend at least in part on the 
presence of Bid. Bid is a BH3-domain-only proapoptotic protein which usually resides in 
an inactive form in the cytosol. After activation of Fas/Fas-L or TNF receptor pathway, 
the amino-terminal portion of Bid is cleaved, the COOH-terminal part of Bid translocates 
onto mitochondria and induces the oligomerization of Bak and Bax into large complexes, 
which forms ion channels in the outer mitochondrial membrane and allows exit of 
cytochrome c (39). Cleavage of Bid to the active, truncated form, t-Bid, is a feature of 
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caspase-8-mediated apoptosis induced via death receptors (40). It has been shown that 
caspase-8 cleave Bid after Asp59 in some cell lines, thereby changing Bid from a 
potential to a strongly pro-apoptotic molecule, capable of inducing cytochrome c release 
and subsequent activation of caspase-9 (41). Bid is also cleaved during apoptosis by 
caspase-3 in the intrinsic pathway to apoptosis, which is independent of death receptors 
(42); by granzyme B (43); by calpains between Gly70 and Arg71 (44); and by lysosomal 
proteases (45). 
The precise mechanism of cytochrome c liberation from mitochondria remains 
elusive, and observations have varied with different cell types and stimulus signals (46). 
It has been proposed that a distinct two-step process is involved in cytochrome c release, 
including disassociation of cytochrome c with its membrane anchor cardiolipin and 
permeabilization of mitochondrial outer membrane by Bax insertion such that disruption 
of A\|im and subsequent ATP depletion compromises cytochrome c release (47). 
Cardiolipin is an anionic phospholipid which is present predominantly in the inner 
mitochondrial membrane. It has been indicated that the disruption of the cytochrome c-
cardiolipin interaction is a crucial initial step for the release of cytochrome c into the 
extra-mitochondrial milieu and for the induction of apoptosis. The peroxidation of 
cardiolipin causes the binding affinity for cytochrome c, a heme protein to decrease, 
which facilitate the detachment of cytochrome c (47). In addition, Ca2+ can bind to and 
induce a conformational change in cardiolipin that can lead to an increase in reactive 
oxygen species (ROS) by the respiration chain, which promotes the oxidation of 
membrane and therefore increase in membrane permeability. 
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Puma (p53-upregulated modifier of apoptosis) and Noxa also belong to the 
proapoptotic BH3-only group of the Bcl-2 family, are well-known direct transcriptional 
targets of p53 (48, 49). They might be involved in mediation of apoptosis that is induced 
by genotoxic damage or oncogene activation. It was shown that Noxa can undergo BH3 
motif-dependent localization to the mitochondria and interact with anti-apoptotic Bcl-2 
family members Bcl-2 and Bcl-xl, leading to cytochrome c release and the activation of 
caspase-9 (49). Puma is an important mediator of p53-induced apoptosis. Studies show 
that Puma expression promotes conformational change and mitochondrial translocation 
of Bax, cytochrome c release and reduction in the mitochondrial membrane potential (50). 
The affinity of p53 and Bax binding is weak in contrast to p53 and Puma binding, thus 
Bax participates indirectly in the death response of p53 through Puma (48). 
p53 also possesses a transcription-independent proapoptotic function that directly 
activating the Bax or Bak (51). The Bax/Bak then promotes mitochondrial outer 
membrane permeabilization (MOMP) (52). Once MOMP occurs, pro-apopto genie factors 
are released, culminating in apoptosis induction rapidly. 
Mitochondrial membrane potential (A\ym) in apoptosis 
The relationship between A\|/m dissipation and apoptosis induction is still 
uncertain. Evidences demonstrate that mitochondrial structure changes and A\|/m 
disruption are early requirements in some regimes of induction of apoptosis. The SV40 
large T antigen induced early A\|/m drop in rat embryo cells undergoing apoptosis (53). 
Human peripheral blood mononuclear induced to undergo apoptosis by dexamethasone 
show a decrease in 3,3' dihexyloxacarbocyanine iodide (DiOCe) uptake prior to 
appearance of any morphological signs of apoptosis (54). Also, thymocytes treated with 
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dexamethasone showed both an early decrease in Aym as examined by 5,5',6,6'-
tetrachloro-l,l',3,3'-tetraethyl benzimidazolylcarbocyannine iodide (JC-1), and 
mitochondrial structure change (55). 
Early loss of A\|/m may occur though caspase-independent mechanisms. Jurkat, 
JMI and U937 cells induced to undergo apoptosis by the nucleoside analogue 2-chloro-
2'-deoxyadenosine, showed A\|/m decrease preceded detectable caspase activation. 
Furthermore, caspase inhibitor z-VAD-fmk inhibited cell death without preventing A\|/m 
dissipation (56). 
Ca2+ has been known to be a key molecule responsible for mPTP opening. The 
opening of mPTP leads to mitochondrial permeability transition (mPT), a sudden increase 
in permeability of the inner mitochondrial membrane to solutes with a molecular mass 
less than 1.5 kD and some proteins. The opening of mPTP causes disruption of A\|/m (57). 
The mPT causes disruption of A\|/m. The apoptosis stimuli which induce cytosolic Ca 
level elevation can trigger early A\|/m decrease prior to caspase activation (58). 
Intracellular calcium chelators can lower the calcium concentration to below the mPTP 
activation threshold and therefore blocking apoptosis signaling pathways. 
However, accumulating data also indicate that there is no early requirement for 
A\|/m loss for apoptosis; A\|/m decrease can be a consequence of apoptosis induction. HL-
60 cells induced to undergo apoptosis by actinomycin-D, etoposide, or staurosporine 
showed detectable A\|/m loss occurred concurrently with cytochrome c release, caspase 
activation, and DNA fragmentation as a late event during the apoptosis process (59). 
Epidermal keratinocytes treated with UV radiation have been reported to undergo 
apoptosis DNA damage within minutes of treatment, and caspases-3 cleavage of protein 
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kinase C delta (PKC8) allows it to translocate to the mitochondrial where it causes the 
loss of A\|/m several hours later (60). Similar findings have been reported in L929 
fibroblast treated with etoposide, five distinct biochemical events have been shown to 
occur with A\|/m collapse as a late event, following nuclear alterations (p53 
phosphorylation) and Bax translocation to the mitochondria (61). 
In conclusion, the role of mitochondrial membrane depolarization in apoptosis is 
still controversial. It raises the possibility that A\|/m decrease may be a subsequent event 
of apoptosis and may serve as an amplifying mechanism for apoptosis processes. 
Involvement of mitochondria membrane potential (Ay/m) in cytochrome c release 
The concept of mPTP opening permits the translocation of several mitochondrial 
proapoptotic proteins during apoptosis has emerged recently (62). However, the 
mechanism of how the mPTP results in these proapoptotic factors release is still unknown 
(63). The molecular composition of mPTP has not yet been fully identified. It has been 
proposed that mPTP consist of the outer membrane voltage-dependent anion channel 
(VDAC), an inner membrane protein adenine nucleotide translocator (ANT), and a 
matrix protein cyclophilin D (CypD). Several other proteins such as peripheral 
benzodiazepine receptors (PBR), creatine kinase (CK), hexokinase and Bcl-2 family 
members (Bcl-2, Bcl-xl, and Bax) are proposed to be involved in the regulation of mPTP 
activity (64). Both the A\|/m and the pH of the mitochondrial matrix operate mPTP 
opening. The decrease in A\|/m promotes mPTP open whereas the acidification of the 
mitochondrial matrix decrease the probability of pore opening (65). 
It remains uncertain whether the loss of A\|/m is actually necessary for cytochrome 
c release to occur. In some cell systems, the mPT is associates with cytochrome c release. 
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In rat hepatocytes, which were induced to undergo apoptosis in response to microcystin-
LR, mPT and subsequent drop in Aym played important roles in cytochrome c release. It 
was shown that cytochrome c release can be inhibited by a specific mPT inhibitor 
(cyclosporin A, CsA), and by various mitochondrial electron transport chain inhibitors 
(66). The decrease in A\|/m which was documented by tetramethylrhodamine methyl ester 
(TMRE) was recorded to coincide with the release of transfected green fluorescent 
protein (GFP)-tagged cytochrome c after staurosporine treatment in pheochromocytoma-
6 cells (67). 
However, some data indicate that mPT and cytochrome c are not strictly 
correlated. In etoposide or N-tosyl-L-phenylalanyl chloromethyl ketone induced-
apoptosis in human monocytic THP.l cells, cytochrome c release was reported to occur 
before mitochondrial membrane potential depolarized and obvious rupture of the outer 
mitochondrial membrane (68). Also, a BH3 death domain peptide corresponding to 
amino acids 53-58 of Bax caused cytochrome c release independent of mPT and A\|/m 
disruption, and therefore without affecting the integrity of inner mitochondrial membrane 
(69). Similarly, it has been shown that the BH3-only Bcl-2 family proteins Bid and Bik 
induce cytochorome c release in a Ca2+-independent manner without A\|/m loss (70, 71). 
Execution pathway 
The extrinsic and intrinsic pathways converge to the point of the executioner 
caspases, caspase-3, caspase-6, and caspase-7. Activation of these caspases is considered 
the final point-of-no-return phase of apoptosis, the cell will be destroyed ultimately once 
executioner caspases are activated. Executioner caspases activate cytoplasmic 
endonucleases and proteases that degrade and cleave various nuclear and cytoskeletal 
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substrates including cytokeratins, poly (ADP-ribose) polymerase PARP, the plasma 
membrane cytoskeletal protein alpha fodrin, the nuclear matrix protein NuMA and 
others, resulting in widespread morphological and biochemical changes to the cell (72). 
Caspase-3 is the most important executioner caspase and can be activated by any of the 
initiator caspases (caspase-8, caspase-9, or caspase-10). Caspase-3 specifically activates 
the endonuclease CAD responsible for DNA fragmentation at the linker region between 
nucleosomes. In proliferating cells CAD exists as a complex with its inhibitor (ICAD) 
and its DNase activity is suppressed. In apoptotic cells, activated caspase-3 cleaves ICAD 
to release CAD from CAD-ICAD complex, allowing CAD to cleave chromosomal DNA 
within the nuclei (73). Caspase-3 also induces cytoskeletal reorganization and 
disintegration of the cell into apoptotic bodies. 
These mechanisms represent simplified pathways without including extremely 
complicated interactions between caspases and other regulatory molecules. For example, 
caspase-3 can activate pro-caspase-9 (74). Likewise, caspase-6 can activate caspase-3 
(75). Caspase-3 can also be activated via a feedback loop involving the mitochondria, 
amplifying the caspases signal that commits the cell to the death pathway inevitably, but 
how this occurs remains to be elucidated. 
Phosphorylation ofH2AX 
DNA damage plays a major role in human pathology. There are a number of 
exogenous and endogenous factors are known to induce DNA damage, such as UV 
radiation, ionizing radiations (X-rays, y-rays, alpha particles), acridine dye, mustard gas, 
bleomycin, and metabolic process. Acridine dye induce deletion and insertion of single 
base pair in DNA helix (76). Damaged DNA replication forks or from oxidative 
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destruction of deoxyribose residues may also cause DNA breaks. DNA double-strand 
breaks (DSBs) are a type of DNA damage in which two single-strand nicks in the 
complementary double helix of DNA occurs simultaneously and sufficiently close to one 
another in locations, typically within 10-20 base pairs (77). The DSBs is the most lethal 
form of DNA damage that can initiate genomic instability and promote tumorigenesis. 
Many factors such as ionizing radiation and genotoxic drugs may induce DSB formation. 
An early event response to DSBs is the rapid phosphorylation of a histone H2A variant, 
denoted as H2AX, in the position of Ser-139 to form yH2AX (78). This phosphorylation 
event is by far the most studied chromatin modifications linked to DNA damage and 
repair. 
Serine 139 in the distinct carboxy-terminal extension of H2AX is phosphorylated 
by several members of the phophoinositide 3-kinase-related protein kinase (PIKKs) such 
as ATM (ataxia teleangiectasia mutated), ATR (ATM and Rad3-related), or DNA-
dependent protein kinase (DNA-PK) within 1 to 3 minutes after DSBs generation, and the 
number of phosphorylated H2AX molecules is proportional to the severity of the DNA 
damage. ATM kinase is a main physiological mediator of H2AX phosphorylation after 
introduction of DSBs (79). ATM is activated by rapid intermolecular 
autophosphorylation of Serl981, which leads to dissociation of the inactive ATM dimers 
into single protein molecules and initiates ATM kinase activity (79). ATR mediates 
H2AX phosphorylation in cells triggered by the formation of single-stranded DNA 
(ssDNA) and the accumulation of repair intermediates (80). Phosphorylation of H2AX by 
DNA-PK has been shown to occur during apoptotic DNA fragmentation (81), and is 
responsible for the enhanced phosphorylation of H2AX under hypertonic conditions (82). 
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At the sites of DSBs, yH2AX appears to have a important function in the 
accumulation of DNA damage signaling and recruitment of DNA damage response 
(DDR) proteins such as MRE11/NBS1/RAD50, MDC1, 53BP1, and BRCA1 to nuclear 
foci where these proteins interact with yH2AX (83). Moreover, yH2AX promotes 
chromatin remodeling by providing a docking site for protein complex to prevent 
dissociation of break ends and enhance DSBs repair efficiency (84). 
Calpain activation 
In addition to caspase-dependent programmed cell death (PCD), caspase-
independent PCD involves activation of other proteases, e.g., calpain and cathepsins. 
They can be governed by several cellular organelles independently or collaboratively, 
including mitochondria, lysosomes, and the endoplasmic reticulum (ER). Lysosomes can 
cause cellular damage through the release of digestive enzymes. Two lysosomal proteins, 
cathepsin B and D, translocate to the cytosol during PCD, and can become the 
dominatnexecution protease in PCD (85). Cathepsins have also been involved in Bid 
cleavage in the process of caspases activation (45). 
Calpains are a family of intracellular calcium-dependent cysteine proteases, which 
can be divided into ubiquitous, tissue-specific and atypical calpains (86). Ubiquitous 
calpains have two isozyme forms; u-calpain (calpain I) and m-calpain (calpain II) that are 
require micromolar or millimolar calcium concentrations for their activation in vitro, 
respectively (87, 88). The active isozymes consist of a common 30 kD regulatory subunit 
and a unique 80 kD catalytic subunit (89). 
Calcium-activated calpain have many substrate proteins which can directly or 
indirectly lead to cell death upon cleavage. In vitro substrates for calpain include 
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cytoskeletal proteins, kinases and phosphatases, growth factor receptors, transcription 
receptors, integral membrane proteins, ion channels and signal-transducing enzymes (90, 
91)." 
There are several common proteins that can be cleaved by both calpains and 
caspases, such as caspases themselves (pro-caspase-3/-7, -8, -9, and -12), Bcl-2 family 
proteins (Bax, Bcl-2, Bcl-xl and Bid), signal transduction protein (PKC-a and PKC-5) 
and DNA-repair and cell-cycle regulatory proteins (PARP, cyclin D and p53), indicating 
that there is crosstalk between calpains and caspases in the modulation of cell death (92-
95). Calpain may induce apoptosis through mitochondrial pathways by cleaving Bax and 
Bid (92, 96), which in turn trigger the release of pro-apoptotic proteins and downstream 
caspase-dependent (cytochrome c and Smac/DIABLO) or caspase-independent (AIF and 
Endo G) pathways. The fragments of Bax cleavage by calpain is a more potent apoptosis 
inducer than uncleaved Bax (97). Similarly, the BH3 domain of Bid remain intact after 
calpain cleaves between Gly70 and Arg71, thus the pro-apoptotic activity of Bid is 
maintained (98). Calpain promotes the intrinsic apoptotic pathway via Bcl-2 inactivation 
in LCLC 103H lung carcinoma cells treated with the calcium ionophore ionomycin (99). 
It is also shown that calpain is able to mediate Bid cleavage in cisplatin-induced 
apoptosis, which is important in chemotherapy agent triggered cell death (44). Also, 
calpain is involved in Bid cleavage mechanisms in nsPEF-induced cell death in E4 
squamous cell carcinoma (SCC) in vitro (100). Furthermore, calpain activation 
subsequent to an elevation of intracellular Ca released from mitochondria has been 
shown to cause apoptosis without the activation of caspase-3 and caspase-9 in rat 
hepatocytes treated with microcystin-LR (MLR), a specific hepatotoxin (66). Although 
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calpain has been reported to play an active role in apoptosis-related signaling pathways, 
compared to caspases, only little is known about the precise roles of calpain in apoptosis. 
Nanosecond pulsed electric fields (nsPEFs) and cell death 
Utilizing nsPEFs has been shown to be a new method of activating apoptosis 
signaling pathways (101, 102). NsPEFs are non-ionizing electric fields which are 
characterized by ultrashort duration (nanosecond range), high power (megawatts), low 
energy density (mJ/cc) and non-thermal (103). Comparing to conventional 
electroporation pulses, which is used to create transient pores in plasma membrane for 
introducing large molecules into the cells by the application of a short (|o,s to ms) electric 
field pulse, nsPEFs have effects on both plasma membrane and intracellular membranes 
(104). 
It has been shown that nanosecond pulses with duration shorter than the charging 
time of the outer cell membrane (100 ns) and high electric field amplitudes can allow 
access to the cell interior and physically manipulating intracellular cell structures and 
functions without irreversibly porating the plasma membrane. 
Experimental results have indicated that nsPEFs affect plasma membrane 
structure, including invoking the loss of phosphatidylserine (PS) asymmetry (101) and 
facilitating the uptake of dyes such as propidium iodide (PI) or ethidium homodime (105, 
106). Accumulating results indicate that nsPEFs might manipulate intracellular 
mechanisms through plasma membrane. Hallmarks of apoptosis, such as PS 
externalization, caspase activation, cytochrome c release and DNA fragmentation have 
been observed after nsPEFs exposure. Other applications of nsPEFs are also shown to 
trigger the release of intracellular calcium from internal stores (107-109), permit sodium 
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entry into the cell (108), promote human platelets aggregation (110), induce action 
potentials in cardiac myocytes (111), induce calpain activation (100) and completely 
eliminate B16fl0 murine melanoma without recurrence in vivo (112-114). However, in 
this dissertation, apoptosis induction is a primary motive. 
Apoptosis has been observed in human Jurkat, HCT116 and HL-60 cells in vitro 
exposed to pulses of 10-300 ns, and up to 300 kV/cm (101, 107, 115, 116). It is indicated 
that apoptosis was initiated upon the electric field amplitude exceeding the threshold, 
which varies depending on cell types. Apoptosis markers, such as caspases activation and 
cytochrome c release can be detected in a relatively short time frame (tens of minutes) 
following nsPEF-treatment. While Annexin-V binding is often used as an apoptosis 
marker, it is not recommended as an apoptosis marker when in response to nsPEFs, since 
the electric fields can result in externalization of PS as a direct effects (117). 
However, the molecular and cellular mechanisms leading to apoptosis after 
nsPEFs treatment remain obscure. It appears most likely that electroporative 
permeabilization of organelles leads to the translocation of pro-apoptotic factors, such as 
cytochrome c or AIF, from mitochondria to cytosol, ultimately resulting in the execution 
of cell death (53, 118). 
An increase in mitochondrial outer membrane permeability is a crucial step in 
apoptotic cell death. This event allows the release of mitochondrial death factors, which 
facilitate different signaling cascades and eventually cause cell death. The mPTP has 
been known as one of the major players in this process. The opening of mPTP leads to 
solutes (K+, Ma2+ and Ca2+ ions) and water enter the mitochondria, mitochondrial matrix 
swelling and outer membrane rupture and a subsequent nonspecific release of 
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proapoptotic proteins from the intermembrane space into the cytosol (119). Weaver et al. 
hypothesized that mitochondrial membrane electroporation due to very large magnitude 
ultrashort pulse could cause mitochondrial transmembrane voltage change, which bring 
about the opening of the mPTP and hence induction of apoptosis (120). 
The initiation of extensive calcium release is considered to be another candidate 
mechanism for nsPEF-induced apoptosis. It was found that, in experiments on E4 mouse 
SCC, chelating intracellular and (or) extracellular calcium with BAPTA and EGTA 
inhibited Bid cleavage and t-Bid generation, which is believed to be the interconnection 
between intrinsic pathway and extrinsic pathway (100). However, experimental studies, 
in which Jurkat human T lymphocyte cells, HL-60 human promyelocytic leukemia cells 
and B16fl0 mouse melanoma cells were exposed to nsPEFs in the presence of EGTA and 
BAPTA, have shown that calcium had relatively little or no impact on caspase activation, 
though calcium clearly plays a role in other aspects of apoptosis (105). 
NsPEFs and cancer treatment 
Electrical pulses have been introduced to cancer treatment since 1980s, where 
short, high voltage pulses are usually used to transiently permeabilize the cell membrane 
and facilitate the delivery of lipophilic chemicals, such as bleomycin, cis- and 
carboplatinum. This approach is called electrochemotherapy (ECT) (121). ECT employs 
reversible electroporation pulses (typically a sequence of eight 100 ms pulses of 
approximately 1000 V/cm) to reversibly facilitate the penetration into cells of small 
amounts of drugs, gene materials, proteins and other large molecules. Although the 
application of ECT greatly enhances the cytotoxicity of chemotherapeutic drugs, it still 
cannot completely avoid deleterious side effects. 
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The inactivation of apoptotic machinery, which gives rise to excessive 
proliferation and dysregulated accumulation of tissue mass, is generally regarded as a 
hallmark in the development and progression of cancer (122). The ability of cancer cells 
to evade apoptotic mechanisms can play a significant role in the resistance to 
conventional therapeutic regimens. Thus, exploiting apoptosis as a further therapeutic 
strategy to trigger tumor-selective cell death without compromising normal cell function 
are of importance. 
Necrosis, characterized by plasma membrane rupture, always accompany with 
inflammatory response and detrimental effect to surrounding cells and tissues. In contrast 
to necrosis, apoptosis is considered as "cell suicide". It is associated with rapid removal 
of cell corpses by phagocytic cell that recognize "eat-me" signals on the outer membrane 
of the apoptotic cells (8, 9). This makes apoptosis a desirable target mechanism for 
cancer treatment. Furthermore, apoptosis mechanisms are frequently altered in cancer 
cells. It provides the opportunity for selectively killing of cancer cells without affecting 
normal cells. 
Accumulating experimental results has demonstrated the effectiveness of nsPEFs 
on elimination of cancer cells. In vivo experiment showed a significant apoptosis with 
reduced tumor size and weight in B10.2 mouse fibrosarcoma tumors after treatment with 
nsPEFs (123). Nuccitelli et al. found that pulsed electric fields greater than 20 kV/cm 
with rise times of 30 ns and durations of 300 ns caused tumor cell nuclei to rapidly shrink 
and ceased blood flow to the tumor (113). Furthermore, a long-term in vivo study showed 
that both necrosis and apoptosis were triggered in murine melanoma with application of 
300, 40 kV/cm, 300 ns electrical pulses. Complete tumor remission without recurrence 
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was found within 180 days after treatment (112). A most recent result indicated that 
murine skin melanomas could be eliminated with an optimized single treatment using the 
pulse parameters (2,000 pulses, 100 ns in duration, 30 kV/cm in amplitude at a pulse 
frequency of 5-7 pulses/sec) (124). It has been reported that melanoma shrinkage is 
associated with activation of executioner caspases, which remain active 2-8 hours after 
treatment, indicating apoptosis is induced by nsPEFs in melanoma in vivo (114). Recent 
unpublished studies indicated that mouse hepatoma (Hepa 1-6) that were exposed to 
nsPEFs ex vivo and in vivo exhibit DNA fragmentation, elevated caspase activity, and 
shrank tumor size (Chen et al, submitted). 
Furthermore, nsPEFs can affect cancer metastasis and angiogenesis. It was found 
that nsPEFs could reduce the possibility of lymphatic metastasis by destructing lymphatic 
capillaries around cancer (125). Reduction in blood flow was detected after nsPEF-
treatment (113). Several molecular indicators for anti-angiogenesis, such as decreased 
vessel numbers, vascular endothelial growth factor (VEGF), platelet derived endothelial 
cell growth factor (PD-ECGF), CD31, CD35 and CD 105 were found within one week of 
electric field application (114). 
SPECIFIC AIMS 
Apoptosis is the most common physiological mechanism by which the organism 
eliminates unwanted cells. Apoptosis plays a crucial role in embryogenesis, tissue 
remodeling, immune regulation, cellular homeostasis and tumor regression. Several 
studies showed that nsPEFs induce cell death in a variety of cancer cells and tumors. 
However, the cellular and molecular mechanisms underlying nsPEF-induced apoptosis 
are still unclear. My overall goal is to gain greater insight into nsPEFs-induced cell death 
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mechanisms including apoptosis in cutaneous cancer cell lines and selective Jurkat cell 
clones as a necessary prerequisite to the development of nsPEFs as a novel anticancer 
treatment. The hypothesis is that nsPEFs can induce apoptosis, and mechanisms are not 
limited to caspase-dependent pathways; activation of caspase-independent mechanisms 
that cross-talk with caspase-dependent mechanisms are also involved. The specific 
hypothesis behind these studies is that nsPEFs eliminate cancer cells through activating 
multiple apoptosis pathways in a cell type-dependent manner. Successful realization of 
these aims will provide a comprehensive assessment of nsPEF mechanisms to eliminate 
cancer cells. Based on results from in vitro and in vivo melanoma studies (105, 114), 
these in vitro results obtained here should translate to tumor cells in vivo. 
The Specific Aims of this dissertation are as follows: 
Specific Aim 1: To determine whether nsPEFs induce cell death in E4 cells and Jurkat 
cells (wildtype, FADD deficient, caspase-8 deficient clones) through apoptosis. 
Specific Aim 2: To determine involvement of caspase-independent mechanisms in 
nsPEF-induced apoptosis in E4 cells and Jurkat clones in vitro 
Specific Aim 3: To determine the signaling pathways for caspase-dependent apoptosis 
mediated by nsPEFs in E4 cells and Jurkat clones in vitro 
SIGNIFICANCE 
Cancer is the second leading cause of death in America, accounting for 
approximately 23% of all deaths (126). Until now, cancer is still difficult to treat in spite 
of many treatment modalities. There are additional barriers within solid tumors that 
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hinder penetration of drugs to heterogeneous and irregularly vascularized tumor tissue 
and thereby failing to reach therapeutic levels within all the cancer cells (127, 128). 
Accordingly, local therapies that kill all cancer cells by inducing apoptotic machinery 
within a selected tissue area are of great interest, especially when they can be detected 
and treated early. 
The application of nsPEFs has been shown to be an effective localized low-energy 
treatment without the additional requirement of chemotherapeutic agents and obvious 
inflammatory response at the treatment site (129). Better understanding of the molecular 
mechanism(s) of nsPEF-induced cell death will advance the development of this targeted 
strategy to be a novel way for the treatment of cancer. 
Defects in apoptosis are considered to be a major hallmark of cancer, and 
contribute to drug resistance and recurrences of cancer therapy (122). One of the ultimate 
therapeutic goals in cancer treatment is to trigger apoptotic machinery in cancer cells to 
induce their suicide. Thus, direct initiation of cancer cell apoptosis mechanisms 
constitutes an appealing approach for the treatment of cancer. 
Once death receptors and mitochondria pathways are activated, these death 
receptors and proteins released from mitochondria trigger apoptosis signaling and, hence, 
they can regulate cell death. By modulating apoptosis machinery of cancer cells, nsPEFs 
should be capable of enforcing cancer cells' own cell death. Since alterations of apoptosis 
mechanisms invariably accompany tumorigenesis, unraveling nsPEFs-induced apoptosis 
mechanisms could help design nsPEFs as a new therapeutic approach for treating cancer. 
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CHAPTER II 
AN APOPTOSIS TARGETED STIMULUS WITH NANOSECOND PULSED 
ELECTRIC FIELDS (NSPEFS) IN E4 SQUAMOUS CELL CARCINOMA 
ABSTRACT 
Stimuli directed towards activation of apoptosis mechanisms are an attractive 
approach to eliminate evasion of apoptosis, a ubiquitous cancer hallmark. In these in vitro 
studies, kinetics and electric field thresholds for several apoptosis characteristics are 
defined in E4 SCC exposed to ten 300 ns pulses with increasing electric fields. Cell death 
was >95% at the highest electric field and coincident with phosphatidylserine 
externalization, caspase and calpain activation in the presence and absence of cytochrome 
c release, decreases in Bid and mitochondria membrane potential (A\|/m) without apparent 
changes reactive oxygen species levels or in Bcl-2 and Bcl-xl levels. Bid cleavage was 
caspase-dependent (55-60%) and calcium-dependent (40-45%). Intracellular calcium as 
an intrinsic mechanism and extracellular calcium as an extrinsic mechanism were 
responsible for about 30 and 70% of calcium dependence for Bid cleavage, respectively. 
The results reveal electric field-mediated cell death induction and progression, activating 
pro-apoptotic like mechanisms and affecting plasma membrane and intracellular 
functions, primarily through extrinsic-like pathways with smaller contributions from 
intrinsic-like pathways. NsPEFs trigger heterogeneous cell death mechanisms in E4 SCC 
populations to delete them, with caspase-associated cell death as a predominant, but not 
an unaccompanied event. 
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INTRODUCTION 
The administration of nsPEFs is emerging as a novel stimulus for inducing cell 
death. Apoptosis can be activated by nsPEFs in various cancer cell lines in vitro (101, 
105, 115), a fibrosarcoma tumor ex vivo (101, 107, 123, 130) and in B16fl0 melanoma 
tumors in vivo (114). Apoptosis is a highly conserved mechanism in eukaryotes for 
eliminating superfluous, aberrant and damaged cells. It is a complex cascade of events 
morphologically characterized by phosphatidylserine externalization, cell shrinkage, 
chromatin condensation, nucleosomal DNA fragmentation, disruption of mitochondrial 
membrane potential (A\|/m) resulting in plasma membrane blebbing and formation of 
apoptotic bodies (131). These morphological features are believed to be caused at least in 
part by activation of caspases, a family of cysteine proteases, which plays a crucial role to 
initiate and execute apoptosis (9, 132, 133), although other proteases may also be 
activated. 
Caspases can be triggered through extrinsic death receptor pathways or intrinsic 
pathways depending on the cell type and stimulus (1, 134). Extrinsic pathway are 
initiated by specific ligands, such as Fas and TRAIL, which aggregate their cognate death 
receptor, allowing assembly of death-inducing signaling complexes (DISC) on the 
cytoplasmic side of plasma membranes leading to initiator caspase-8 (and/or -10) 
activation. In type I cells, caspase-8 activates executioner caspases independent of 
mitochondria. Whereas, is type II cells, Bid was cleaved to pro-apoptotic truncated Bid 
(t-Bid). Translocation oft-Bid triggers cytochrome c release from mitochondria and 
caspase-9 activation through formation of the apoptosome, which causes cell demise 
through activation of caspase-3. 
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Unlike conventional electroporation, which primarily affects plasma membranes 
(135, 136), nsPEFs also electroporate intracellular membranes (104). Modeling studies 
(135-138) and evidence determined experimentally by patch clamp and fluorescent 
imaging studies (139, 140), indicated that nsPEFs with sufficiently short pulse durations 
and rapid rise times (104) induced nanopores in plasma membranes that were often 
smaller than propidium iodide (PI). This supra-electroporation involved all cell 
membranes going through cells, extensively penetrating all organellar membranes (135, 
136). Effects on intracellular vesicles were observed without measurable effects on 
plasma membranes (104, 141) with PI or calcein and on intracellular calcium 
mobilization from the endoplasmic reticulum and capacitative calcium entry in HL-60 
cells (109), suggesting that these external electric fields can mimic ligand signaling (107). 
It is now know that the absence of effects on plasma membranes was due to the presence 
of nanopores that were too small to allow entry of the membrane markers or that 
detection systems were insufficiently sensitive to measure them (139, 140). Nevertheless, 
modeling evidence suggests that under certain circumstances it is possible to have effects 
on intracellular membranes without effects on the plasma membrane (138). 
Studies have suggested that nsPEF-induced apoptosis mechanisms are cell type-
dependent. In Jurkat cells caspase activation and cytochrome c release were nearly 
coincident, making it difficult to differentiate between extrinsic and intrinsic mechanisms 
(101). In B16fl0 cells cytochrome c was not released, implicating the extrinsic apoptosis 
pathway typical of type I cells (105). In HCT 116 cells, caspase activation occurred 
before cytochrome c release, suggesting activation of extrinsic pathways followed by 
mitochondria-mediated cytochrome c release through the intrinsic pathway, type II cell 
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extrinsic apoptosis pathway and/or feed-forward amplification from the initial extrinsic 
signal (115). However, specific contributions from extrinsic or intrinsic mechanisms have 
not been determined. 
Available data indicate pervasive effects of nsPEF on all cell membranes inducing 
apoptosis signaling in several cell types. However, their mechanisms, sites of action and 
unambiguous confirmation of apoptosis pathways contributing to cell death have not 
been clearly determined. In this study, we demonstrate direct activation of apoptosis 
signaling through multiple mechanisms and quantify relative contributions from several 
apoptosis pathways originating from both plasma membranes and intracellular 
membranes that exhibit both dependence and independence of caspases, calpains, 
calcium, and cytochrome c release. Several quantified nsPEF-induced biological 
functions exhibit different electric field sensitivities and kinetics that promote 
heterogeneous apoptosis characteristics in E4 squamous carcinoma cells (SCC). Diverse 
effects of nsPEFs on different E4 SCC death mechanisms and programmed pathways can 
induce cell death by multiple mechanisms bypassing apoptosis-deficient syndromes in 
SCC. 
MATERIALS AND METHODS 
Cells and cell culture—The E4 murine squamous cells were obtained from Dr. 
Jian-Hua Mao (Lawrence Berkeley National Laboratories) and were maintained in 
Dulbecco's modified Eagle's medium (ATCC) supplemented with 10% fetal bovine 
serum (FBS, Atlanta Biologicals), 2mM L-glutamine (Mediatech Cellgro), and 1% 
Penicillin-Streptomycin solution (Mediatech Cellgro). The cells were cultured in a humid 
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atmosphere containing 5% CO2 and 95% air at 37°C until reaching 50-75% confluency 
with passage ranging between 11 and 19. 
Induction of cell death by nanosecond pulsed electric fields—Cells were 
harvested with trypsin and resuspended in fresh DMEM medium with 10% FBS to a 
concentration of 7.7x 10 cells/ml. 130ul of cell suspension (1x10 cells) were placed in 
0.1 cm gap cuvettes (Biosmith) and exposed to ten pulses with 300ns duration and 
electric field strength from 0-60 kV/cm. The pulse power devise was previously 
described (115). The energy absorbed or the dose (J/g) was calculated as previously 
described (142). The Frank Reidy Research Center for Bioelectrics provides a course to 
present the safe use of high voltage pulse power equipment. The authors have been 
trained in the safe use of this equipment. For all cell responses, time courses were 
conducted to determine time for maximal responses. Cell responses at all electric fields 
were stable for at least 90 minutes. 
Determination of24hr cell survival—After treatment, E4 cells were seeded in 6-
well plates (3.3xl05 cells/well). Twenty four hours later, cells were detached and trypan 
blue negative cells were counted. The cell numbers were normalized to control cells as 
100%. 
Assessment ofcaspases-3 & -7, -8, -9 activation by flow cytometry—Caspase-3&-
7,-8, -9 activation were assayed using a commercial method based on fluorochrome-
labeled, irreversible caspase inhibitors (FLICA, Immunochemistry Technologies LLC). 
E4 cells were treated with different nsPEF conditions as mentioned above. One hour after 
treatment, cells were gently removed from cuvettes and resuspended in DMEM without 
FBS. According to the manufacturer's recommendations, cells were labeled with 
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carboxyfluorescien caspase-3 &-7, -8, -9 irreversible inhibitors for 1 hour at 37°C under 
5% CO2 and protected from light as previously described (105). Cells were washed with 
buffer to remove the unbound reagent. Cell fluorescence was determined by Becton 
Dickinson FacsAria. Ten thousand (10,000) cells were acquired for analyses and 
expressed as percentage of cells showing positive fluorescence. As electric fields were 
increased, greater numbers of cells became caspase positive with homogeneous shifts of 
cells into the caspase positive gate, making cell percentages with active caspases the most 
accurate and meaningful quantification of active caspases as an apoptosis marker. 
Evaluation ofactive pan-caspase by flow cytometry—E4 cells were exposed to 
specific nsPEF conditions as previous described and incubated with 40uM fluorescent-
labeled, cell permeable, irreversible inhibitor FITC-VAD-fmk (CaspACE™, Promega) 
for 20 min. Cells were washed once with 1ml PBS and resuspended in 500uL PBS 1 hour 
post pulse for flow cytometric analysis with Becton Dickinson FacsAria. 
Measurement of cytochrome c release by two different assays—Cytochrome c 
release was measured by two different methods, which gave similar results (data not 
shown). In method I cytochrome c, which was used in all studies here, was assessed using 
the Innocyte Flow Cytometric Cytochrome c Release assay (Calbiochem). One hour after 
nsPEF treatment, cells were permeabilized, fixed and washed. Cells were then incubated 
with primary antibody overnight at 4°C and secondary antibody for 1 hour at room 
temperature. Cells (10,000) were then analyzed by Becton Dickinson FacsAria flow 
cytometer. Method II data is not shown but was carried out as previously described (105, 
115). 
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Measurement of mitochondrial membrane potential (Ay/m)—Depolarization of 
the mitochondrial membrane potential was detected using a fluorescent lipophilic cation, 
tetramethylrhodamine ethyl ester (TMRE) (Immunochemistry Technologies LLC). Cells 
were incubated with 200nM TMRE for 10-20 min at 37°C 30 min post pulse. Twenty 
(20) minute incubations were suggested by the manufacturer, but 10 min incubations, 
which gave similar results, were used in some experiments to determine the earliest 
response. At the end of incubation, cells were resuspended in assay buffer. The average 
intensity of red fluorescence (10,000 cells) was analyzed on the FL-2 channel of a Becton 
Dickinson FacsAria flow cytometer. 
Determination of phosphatidylserine externalization—External PS exposure and 
plasma membrane permeability was evaluated by double-labeling cells with FITC-
Annexin-V and PI using a detection kit (BD Pharmingen Biosciences). After 
administration of nsPEFs, cells were resuspended in binding buffer and incubated with 
FITC-Annexin-V and PI according to the manufacture's procedures. The fluorescence 
signal was quantified by flow cytometry using FL1 (Annexin-V) and FL2 (PI) channels 
15 minutes post pulse. 
Assessment of cytochrome c release with administration of z-VAD-fmk—Cells 
were preloaded with lOOuM of z-VAD-fmk for 30 min and followed by exposing cells to 
ten 300ns pulses with 0 and 60 kV/cm electric fields. Cytochrome c monoclonal antibody 
(BD Pharmingen Biosciences) and Alexa-Fluor 488 goat anti-mouse antibody 
(Invitrogen) were added to cell suspensions lh after pulsing as described previously 
(105). Flow cytometric analysis of fluorescent intensity was done by using Becton 
Dickinson FacsAria. 
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Immunoblot analysis for Bcl-2, Bcl-xl, Bid and t-Bid—For each antigen samples 
were taken for immunoblot analysis 0, 15, 30 and 60 min after pulsing. Bcl-2 and Bcl-xl 
data are not shown. At the indicated times E4 cells were washed twice with cold PBS and 
lysed in RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium 
deoxycholate, 0.1% SDS) (Pierce) for 30 min on ice. Then cell lysates were centrifuged 
at 15,000g for 20 min at 4°C and protein content in the supernatant was measured using 
the BCA method (Pierce). Lysates were then boiled with 4x DualColor™ Protein 
Loading Buffer (Fermentas Life Sciences) for 5 min. Protein extracts (75 ug) were 
separated by electrophoresis on 15% SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) and proteins were transferred onto a PVDF membrane with pore size of 0.2um 
(Pierce, Rockford, IL). Membranes were blocked in Odyssey blocking buffer (LI-COR 
Biosciences) for 1 hour, and incubated overnight at 4°C with the respective primary 
antibody directed against Bcl-2 (1:200 mouse polyclonal, Santa Cruz Biotechnology), 
Bcl-xl (1:1000 rabbit monoclonal, Cell Signaling Technology), or Bid/t-Bid (1:100 
mouse monoclonal, R&D System) diluted in blocking buffer. Membranes were washed 
three times with 0.1% Tween-20 in PBS and then incubated with an IRDye680-
conjugated secondary antibody (LI-COR Biosciences) in blocking buffer for lhr. 
Protein-antibody complexes conjugated with IRDye 680 were quantified on the Odyssey 
Infrared Imaging System (LI-COR Biosciences). |3-Actin (1:1000; Li-Cor Biosciences) 
was used as loading control. 
Assessment of inhibitory effects of z-VAD-fmk, EGTA and BAPTA on nsPEFs 
induced-Bid cleavage—E4 cells were preincubated with lOOuM z-VAD-fmk, 5mM 
EGTA, and/or 20uM BAPTA-AM, for 30 minutes followed by nsPEFs treatment. Cells 
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were then quantified by immunoblot analysis using Odyssey for levels of Bid and t-Bid 
as described above. Caspase-dependence was determined by Bid cleavage that was 
inhibited by z-VAD-fmk. Calcium dependence was determined by Bid cleavage that was 
inhibited by EGTA and BAPTA-AM in the absence of z-VAD-fmk. Dependence on 
extracellular calcium was determined by Bid cleavage that was inhibited by EGTA in the 
presence of z-VAD-fmk. Dependence on total calcium was determined by Bid cleavage 
in the presence of EGTA and BAPTA-AM in the presence of z-VAD-fmk. Dependence 
on intracellular calcium was determined by the difference between total calcium and 
extracellular calcium responses. 
Assessment of calpain activity in response to nsPEFs by fluorometric 
assay—Analysis of calpain catalytic activity was determined in total cell lysates 
(BioVision). Cell lysates were prepared and incubated with substrate (AC-LLY-AFC) 
and reaction buffer for 1 hour at 37°C in the dark. Cleavage substrate fluorescence was 
measured by a microplate spectrofluorometer (ex/em = 488/520 nm) with SoftMax Pro 5 
software (Molecular Devices). A calpain-specific inhibitor (z-LLY-fmk) was used to 
identify calpain-specific substrate hydrolysis. Recombinant calpain I was used as positive 
control (data not shown). 
Determination of intracellular Reactive Oxygen Species (ROS) 
accumulations—E4 Cells were preloaded with 1 uM CM-H2DCFDA (5-6-chloromethy-
2', 7'-dichlorodihydrofluorescein diacetate acetyl ester, Molecular Probes) in phenol red 
free DMEM media (Invitrogen) for 60 minutes, and then pulsed with nsPEF as described 
previously (105). Cells were analyzed by flow cytometry at 0, 5, 15, 30, and 60 min after 
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pulsing. Cells incubated at 4°C for lhour were used as positive controls. After removing 
from the cold, these cells were also sampled at 0, 5, 15, 30 and 60 min. 
Statistical analysis—Experiments were performed at least three times 
independently in this study. All the data is expressed as mean ± standard error (SE). 
Statistical differences between control and treated groups were analyzed by student's t-
test (two-tailed) with/) < 0.05 regarded as statistically significant. 
RESULTS 
NsPEFs induce caspase-correlated cell death in E4 squamous carcinoma cells 
(SCC) in vitro in an electric field-dependent manner—To determine cell viability after 
nsPEF treatment and whether nsPEFs activate caspase-associated cell death pathways in 
E4 SCC, cells were exposed to ten 300ns pulses of 0-60 kV/cm electric field strengths. 
We chose ten, 300ns pulses as parameters for this study so we could observe a complete 
range of electric field-dependent effects on cell survival from little of no cell death to 
maximal cell death. Thus, we could observe various cell responses as possible 
mechanisms that were coincident with cell death. Cell viability was determined by 
counting trypan blue negative cells 24 hours post pulse (Fig. 1, top panel). Caspase-3/7, -
8, -9 activations were determined 2 hours after nsPEF administration by flow cytometry 
using a cell permeable, irreversible inhibitors with selectivity towards specific caspase 
isoforms (Fig. 1, bottom panel). Results indicate an electric field-dependent decrease in 
cell viability that was correlated with electric field-dependent increases in percentages of 
cells that exhibited active caspases. Analysis of caspase activation time courses indicated 
that they were activated between 20 and 60 minutes post-pulse using the cell permeable, 
pan caspase irreversible inhibitor, z-VAD-fmk (data not shown). Therefore, nsPEF-
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induced E4 cell death is correlated with early caspase activation. Very few if any cells 
immediately lose plasma membrane integrity indicating that frank necrosis is not a 
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FIGURE 1. NsPEF-induced cell death is correlated with the 
activation of caspase-3/7, -8, and -9 in an electric field amplitude-
dependent manner. E4 cells were pulsed 10 times at 300ns and 
electric field strengths between 0-60 kV/cm. (Top panel) Cell 
viability was determined by counting trypan blue negative cells 24 
hours post pulse and normalizing values to the control. (Bottom 
panel) The percentage of cells with active caspase-3/7, -8, -9 was 
analyzed by flow cytometry using the cell permeable irreversible 
caspase inhibitors FAM-DEVD-fmk (caspase-3), FAM-LETD-fmk 
(caspase-8), FAM-LEHD-fmk (caspase-9) as described in Materials 
and Methods. The values represent the mean± SE (n=3) * indicates/? 
< 0 05 and ** indicates/? < 0.01. 
Different sensitivities and heterogeneous responses in E4 cells to nsPEFs: 
Electric field-dependent effects on plasma membrane indicators, Ay/m, caspase activation 
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and cytochrome c release—Fig. 2 shows electric field thresholds for five different cell 
functional indicators in response to nsPEFs as defined by significant increases in cell 
numbers above basal values in the absence of electric field exposure. These cell 
responses also exhibited different temporal thresholds that were determined by time 
courses (data not shown) prior to experiments shown in Fig. 2. These values are indicated 
with each response. Significant numbers of cells showed increases in PI uptake and 
phosphatidylserine externalization at 24 kV/cm, indicating changes in permeability and 
phospholipid orientation in plasma membranes. These plasma membrane responses were 
present as quickly as they could be measured (minutes) and were stable thereafter for at 
least 2 hours. Fig. 2 illustrates these analyses 15 minutes after pulsing. These effects on 
plasma membranes were electric field-dependent. Essentially all of the cells (95-98%) 
were positive for both markers at electric fields > 42 kV/cm. Cell responses below 42 
kV/cm were heterogeneous for both of these markers with only about 35% and 70% of 
cells showing positive responses at 24 and 32 kV/cm, respectively. For effects on the 
mitochondria membrane potential, a significant increase in the numbers of cells that 
exhibited decreases in A\\im were observed at 42 kV/cm, indicating depolarization of the 
inner mitochondria membrane. Increases in the numbers of cells that showed decreases in 
A\|/m were seen within 10 minutes, the earliest time measured. Fig. 2 shows the response 
with TMRE 15 minutes post pulse. Similar results were observed with JC-1 (data not 
shown). Significant increases in the number of cells expressing active caspases occurred 
at 32 kV/cm and increased in an electric field dependent manner. Cell numbers with 
active caspases are shown in Fig. 2 one hour after pulsing. The temporal threshold for 
increases in cells positive for active caspases was between 20 and 60 minutes. 
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Cytochrome c release required higher electric fields with significant increases in the 
numbers of cells releasing cytochrome c occurring at 42 kV/cm. Thus, cytochrome c was 
the least sensitive indicator tested, was not readily discernable before 1 hour and only 
showed positive responses in about 45% of cells. The 1 hour time point is shown in Fig. 
2. We used two different assays for cytochrome c releases (see Materials and Methods), 
both showing thresholds at 42 kV/cm and no significant differences between them at any 
electric field tested (data not shown). Notice that cell membrane responses (PI, Annexin-
V and A\|/m) were evident at the earliest time tested while biological responses (caspase 
activation, cytochrome c release) required more time. Also notice that at electric fields 
lower than 42 kV/cm, cell numbers with increases in active caspase and decreases in 
A\|/m were observed without significant cytochrome c release. At electric fields greater 
than 50 kV/cm, greater numbers of cells exhibited caspase activation than those with 
decreased A\|/m and released cytochrome c. At electric fields 50 kV/cm and higher, equal 
numbers of cells exhibited decreases in A\|/m and increases in cytochrome c release and 
30-40% of cells did not show active caspases and about 55% did not show decreases in 
A\|/m or increases in cytochrome c release. Although the temporal thresholds were 
different for some of these responses, they were stable for at least 90 minutes under the 
conditions tested. Thus Fig. 2 can represent a 1 hour snapshoot after treatment. However, 
cell responses indicate that these membrane and intracellular markers exhibit 
heterogeneous responses, different electric field sensitivities and different time courses. 
Caspase-dependent and caspase-independent cytochrome c release in response to 
nsPEFs—To determine whether cytochrome c is released through the intrinsic pathway 
or type II cell extrinsic pathway, E4 cells were pretreated with 100 uM z-VAD-fmk, a 
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general caspase inhibitor, and then pulsed ten times at 300 ns, 60 kV/cm in the presence 
of the inhibitor (Fig. 3). Inclusion of 1 mM z-VAD-fmk gave identical results (data not 
shown); indicating that caspase activity was completely inhibited at 100 uM. Cytochrome 
c release was determined 1 hour post pulse by flow cytometry using Method I (see 
Materials and Methods). Fig. 3A shows a contour plot of a typical experiment 
0 "1 1 , . 1 . 1 
0 10 20 30 40 50 60 
nsPEF(kV/cm> 
FIGURE 2. Sensitivity thresholds for nsPEF effects on cell membranes, caspase activation and 
cytochrome c release. E4 cells were exposed to 10 pulses at 300 ns ranging from 0-60 kV/cm and 
percentage of cells that showed significant responses were analyzed by flow cytometry for decreases in 
the mitochondrial membrane potential (A\|/m) with TMRE 15 minutes post pulse, active caspases with 
FITC-VAD-fmk 1 hour post pulse, and cytochrome c using the InnoCyte (Method I) one hour post 
pulse. FITC-Annexin-V and propidium iodide were added immediately after nsPEF exposure and 
incubated for 15 minutes before analysis by flow cytometry. After initial measurements all responses 
were stable for a given electric field for at least 90 minutes. Values are presented as percent cells with 
positive responses. The graph represents the mean ± SE (n=3). * indicates/? < 0.05 and ** indicates/? < 
0.01. 
with forward scatter on the Y-axis (FSC-A) and cytochrome c fluorescence on the X-axis 
(FITC-A). Cells that exhibit cytochrome c release appear in the bottom right quadrant. 
Fig. 3B shows the combined results of three separate experiments with statistical 
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comparisons. In sham treated control cells, very few cells show cytochrome c release (7.7 
± 1.5%) and the caspase inhibitor has no significant effect (9.5 ± 2.2%). When cells were 
treated with ten 300ns pulses at 60 kV/cm, 46.2 ± 2.5% of cells exhibited cytochrome c 
release and the caspase inhibitor decreased that to 26.2 ± 4.6%. Three separate 
determinations gave similar results (Fig. 3B). Thus, based on the mean values in these 
experiments 43.3% of cytochrome c release was caspase-dependent and 56.7% was 
caspase-independent, indicating more than one mechanism for cytochrome c release in 
response to nsPEFs. 
control A . control+Z-VAD-fmk 
FIGURE 3. A caspase inhibitor (z-VAD-fmk) partially decreases nsPEF-induced 
cytochrome c release. E4 cells were pre-incubated with lOOuM z-VAD-fmk, a pan caspase 
inhibitor, for 30min and then pulsed ten times with 300ns pulses at 60 kV/cm or sham 
treated. Cells were analyzed by flow cytometry for cytochrome c release 1 hour post pulse 
using Method I as described in Materials and Methods. A, Representative contour plots are 
shown with forward light scatter (FSC-A) on the Y axis and cytochrome c fluorescence 
(FITC-A) on the X-axis. The top panels show sham treated control cells in the absence (left) 
and presence (right) of z-VAD-fmk. The bottom panels show cells treated with nsPEFs in 
the absence (left) and presence (right) of z-VAD-fmk. A decrease in cytochrome c release is 
shown as a decrease in fluorescent intensity (shift from lower right quadrant to lower left 
quadrant) after preincubation with lOOuM z-VAD-fmk. B, The percentage of cells 
exhibiting cytochrome c release is presented as mean ± SE (n=3). ** represents/) < 0.01. 
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NsPEFs generate Bid cleavage to truncated Bid (t-Bid)—A well-characterized 
mechanism for caspase-dependent cytochrome c release is through the cleavage of the 
BH3 only protein, Bid to the pro-apoptotic form t-Bid (40). Such a possibility was also 
likely given that caspase activation was observed at lower electric fields and earlier times 
than cytochrome c release. To determine if t-Bid was present, we analyzed cells that were 
exposed to ten 300ns pulses at 60 kV/cm and then used immunoblot analysis to determine 
the quantities of Bid and t-Bid using quantitative Odyssey imaging at times after 
treatment with an antibody that recognized both Bid forms (Fig. 4). The left panel shows 
a typical immunoblot experiment of Bid and t-Bid in response to ten 300ns pulses at 60 
kV/cm, a condition that resulted in significant cytochrome c release (see Fig. 2 and 3). 
The panels on the right show quantitative relationships of relative percentages oft-Bid 
(top) and Bid (bottom) over a 60 minute time course. In a time-dependent manner, there 
were increases in t-Bid and coordinate decreases in Bid. The sums of fluorescence 
intensities of both Bid forms were essentially the same at each time point, consistent with 
nsPEF-induced cleavage of Bid to generate pro-apoptotic t-Bid. At 60 minutes after 
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FIGURE 4. NsPEFs induce Bid cleavage in a time-dependent manner in E4 cells. E4 cells were 
exposed with or without ten 300ns pulses at 60 kV/cm. Whole cell extracts (75 ug protein) were 
separated by SDS-PAGE, transferred to PVDF membranes and probed with an anti-Bid antibody. 
(Left panel) Bid (22 kDa) and t-Bid (15 kDa) levels were determined 0, 15, 30 and 60 minutes post 
pulse by immunoblot analysis in a representative experiment as described in Material and Methods. 
Quantification was performed after normalizing Bid (0 min) or t-Bid (60 min) to maximal levels. The 
right panel shows quantification of three experiments like the typical one shown in the left panel. 
Values > 30 minutes are statistically significant (** is/? < 0.01). 
NsPEFs induce caspase-dependent and calcium-dependent Bid cleavage; 
Repetitive mechanisms for cytochrome c release—The data in Fig. 3 using z-VAD-fmk 
indicated that nsPEF-induced cytochrome c release, which is regulated at least in part by 
Bid cleavage, could be accounted for through caspase-dependent and caspase-
independent mechanisms. Since nsPEFs induced Bid cleavage and proteases other than 
caspases can cleave Bid, including calcium-dependent calpains (44, 92), we investigated 
the caspase- and calcium-dependency of Bid cleavage in response to nsPEFs (Fig. 5) as 
well as the possibility for nsPEF-induced calpain activity (Fig. 6). It was also of interest 
to determine whether the calcium was mobilized from intracellular stores, suggesting an 
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intrinsic mechanism, or from extracellular media through plasma membranes as an 
extrinsic mechanism. Caspase-dependence was determined in the presence and absence 
of z-VAD-fmk and the absence of EGTA and BAPTA. Determining caspase-dependent 
Bid cleavage in the presence of calcium was justified by the observations that caspase 
activity was shown to be independent of calcium (105, 115). Calcium dependence was 
determined in the presence and/or absence of EGTA and BAPTA-AM. These analyses 
considered Bid cleavage to be either caspase- or calcium-dependent. To determine total 
calcium dependence from intracellular and extracellular compartments, caspases were 
inhibited by z-VAD-fmk. Thus, these values represent only the calcium component. The 
effect of extracellular calcium was determined in the presence and absence of EGTA and 
total calcium effects were determined in the presence and absence of EGTA and BAPTA. 
Intracellular calcium dependence was determined by the differences in total and 
extracellular calcium effects. The analyses were carried out in five to seven separate 
experiments by quantitative immunoblot analysis using Odyssey imaging of Bid 
experiments shown in Fig. 4. The results in Fig. 5 show that about 60% of Bid cleavage 
was attributed to caspases, while about 50% was attributed to calcium-dependent 
proteolysis. The differences are not statistically different, suggesting that effects of 
caspase- and calcium-dependent mechanisms contribute about equally to Bid cleavage. 
These slightly overlapping percentages could be due to a small amount of cross-
dependence for caspase and calcium requirements, but are within reason of experimental 
variations. Further analyses indicated that 60-70% of the calcium contributing to Bid 
cleavage comes from extracellular sources through plasma membranes and 30-40% 
comes from intracellular stores. 
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NsPEFs induce calpain activity—It was possibility that calcium-dependent Bid 
cleavage in response to nsPEFs was due to calpain activation. To test this, E4 cells were 
treated with ten 300ns pulses at 60 kV/cm in the presence or absences of BAPTA and 
EGTA, which inhibits intracellular and extracellular calcium-mediated events, 
respectively, and z-LLY-fmk, which specifically inhibits calpain activity. One hour after 
treatment cell extracts were prepared and assayed for calpain activity using the substrate 
AC-LLY-AFC. In the absence of these inhibitors/chelators, basal calpain activity was 
about 50 units and nsPEFs increased this activity 1.7-fold. In the presence of the calpain 
inhibitor, both basal and nsPEF-stimulated activities were decreased by about 50%. In the 
presence of BAPTA and EGTA, basal activity was not significantly affected, but nsPEF-
stimulated activity was inhibited by >50%. When calcium chelators and the calpain 
inhibitor were present, basal activity was not inhibited any greater than when the calpain 
inhibitor was present alone. NsPEF-stimulated activity was inhibited by >80%. This data 
indicate that E4 cells exhibit calcium-insensitive basal calpain activity and calcium-
sensitive nsPEF-stimulated activity. Although not tested here, these data suggest that 

























FIGURE 5. Inhibition of Bid cleavage by calcium chelators EGTA and BAPTA and 
caspase inhibitor z-VAD-fmk. E4 cells were pre-incubated for 30min in the presence or 
- absence of EGTA (5mM, to chelate extracellular calcium), BAPTA-AM (20uM, to chelate 
intracellular calcium) and/or z-VAD-fmk (lOOuM to inhibit caspase activation) prior to 
nsPEFs administration. Cells were exposed to ten 300ns pulses at 60 kV/cm or sham treated 
and cell lysates were prepared 1 hour post pulse as described in Material and Methods. Bid 
and t-Bid was quantified using Odyssey infrared imager (see Figure 4) and normalized to total 
Bid levels in control. Caspase-dependent Bid cleavage was taken as the percent cleavage 
inhibited by z-VAD-fmk. Calcium-dependent Bid cleavage was taken as cleavage inhibited by 
BAPTA and EGTA. To determine only calcium contributions, z-VAD-fmk was used to 
inhibit the caspase component. Total calcium-dependent (intracellular plus extracellular) Bid 
cleave was taken as cleavage that wasinhibited by EGTA and BAPTA. Extracellular calcium-
dependent Bid cleavage was taken as cleavage inhibited by EGTA. Intracellular calcium 
dependent Bid cleave was taken as the difference between cleavage of the total calcium 
component minus the extracellular calcium component. Values are expressed as mean ± SE 


















FIGURE 6 NsPEFs induce calcium-dependent calpain activity in E4 
cells. Calpain activity was determined by a calpain activity assay. E4 cells 
were pretreated with or without BAPTA-AM (20 uM) and EGTA (5mM) for 
30 min followed by exposing to ten 300ns at 60 kV/cm or left untreated. Cells 
were then lysed and calpain activity was determined with or without adding 
calpain inhibitor z-LLY-fmk (200 uM) to lysates. Data are expressed as mean 
± SE (n=3). * indicates/? < 0 05. 
NsPEFs induce cell death without ROS generation or changes in pro-survival 
protein Bcl-2 and Bcl-xl—To determine whether ROS generation contributes to nsPEF-
induced apoptosis, E4 cells were pulsed in the presence of CM-H2DCFDA and mean 
fluorescence intensity was analyzed by flow cytometry 0, 5, 15, 30, 60 min post pulse 
(Fig. 7). Treatment of cells for 1 hour at 4°C increased ROS by 5-fold. ROS levels 
quickly decreased in a time-dependent manner to near control levels by 1 hour, 
demonstrating significant antioxidant activity in E4 SCC. In response to nsPEFs E4 cells 
show a slight electric field dependent increases that were not statistically significant. 
Unlike the positive control, no time dependent decreases in ROS levels were observed 
after pulsing. These results suggest that nsPEFs have minimal effects ROS generation 
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FIGURE 7. Measurements of ROS generation in E4 cells after nsPEFs 
exposure. E4 cells were preincubated with ROS indicator CM-H2DCFDA for 60 
minutes and exposed to ten pulses at 300ns between 0-60 kV/cm. Intracellular ROS 
formation was evaluated by measuring fluorescent intensity 5, 15, 30, 60 min post 
pulse by flow cytometer. For the positive controls cells incubated at 4°C for lh and 
removed at the indicated time for measurement of ROS levels. The graph represents 
the mean ± SE (n=3). ** represents p< 0.01 for differences at the indicated time 
compare to the control at 0 kV/cm. 
NsPEF have no significant effects of Bcl-2 or Bcl-xl levels—In a further analysis 
of nsPEF effects, levels of the anti-apoptotic proteins Bcl-2 and Bcl-xl were analyzed in 
the absence and presence of nsPEF treatment in E4 cells using quantitative immunoblot 
analysis with Odyssey imaging (data not shown). Both Bcl-2 and Bcl-xl were present a 
single bands in control cells. There were no effects often 300ns pulses at 60 kV/cm on 
either anti-apoptotic protein with the first hour after treatment with nsPEFs, suggesting 




Evidence from E4 SCC gives new insight and understanding for cell death and 
apoptosis-like mechanisms and their origin in response to nsPEFs. In the experiments 
presented here we quantified a diverse set of cell responses to nsPEFs in E4 SCC. The 
results indicate that cell death can be dependent and/or independent of caspase activity, 
calpain activity, calcium from intracellular stores or extracellular media, cytochrome c 
release and decreases in A\j/m. Thus, nsPEFs initiated charge-mediated events in plasma 
membranes and intracellular membranes through multiple signaling mechanisms 
inducing signatures of apoptosis and other forms of cell death. Even at the highest 
electric fields investigated, frank necrosis as defined by immediate plasma membrane 
rupture was not present, so cell death is driven by biological responses that appear to be, 
at least in part, programmed. Ibey et al. (143) found that apoptosis (DNA fragmentation 
of agarose gels) was present in U937 cells exposed to 600 pulses at 10 ns and 100 kV/ cm 
(700 J/g); however, necrosis was a major form of cell death. However, in this study the 
cell type was different and the energy absorbed or dose (J/g) for the pulses was about 
seven times higher than in the present study (-700 vs. -100 J/g). It should be pointed out 
that factors other than energy absorbed are likely involved to determine nsPEF effect 
(144). 
After treatment with nsPEFs caspases are activated at earlier times and at lower 
electric fields than cytochrome c release, demonstrating initial activation of a type I cell 
extrinsic pathway. This is similar to results in nsPEF treated HCT-116 colon carcinoma 
cells (115), but different than B16fl0 cells that did not release cytochrome c (105) and 
Jurkat cells with concomitant cytochrome c release and caspase activation (101). This 
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clearly defines cell type-specific response to nsPEF-induced cell death. Unlike the other 
analyzes, here we show for the first time caspase-dependent and caspase-independent 
cytochrome c release, demonstrating the additional presence of a type II cell extrinsic 
pathway through Bid cleavage for cytochrome c release. Caspase-dependent (55-60%) 
and calcium-dependent (40-45%) Bid cleavage pathways were demonstrated with 
quantitative and reciprocal increases in t-Bid and decreases in Bid. Further, for calcium-
dependent Bid cleavage, extracellular calcium (-70%) played a predominant role 
compared to calcium from intracellular stores (-30%). Caspase-independent Bid cleavage 
is most likely accomplished by charge-mediated interventions with calcium signaling 
from and/or nanoporation in the endoplasmic reticulum, capacitative calcium entry (107, 
109) and/or calcium entry through nanopores in plasma membranes (140). Since caspase 
activation has been shown to be calcium-independent (105, 115), calcium-dependent Bid 
cleavage appears to be due to calpain activation. This was confirmed by showing 
calcium-sensitive calpain activity was specifically inhibited by the calpain inhibitor z-
LLY-fmk. Taken together, these results show for the first time nsPEF-mediated at least 
two mechanisms for Bid cleavage and cytochrome c release—one caspase-dependent and 
one calpain-dependent. While there are reports of cross-talk and/or synergistic behaviors 
between calpains and caspases (95, 145), since the sum of caspase-dependent and 
calpain-dependent Bid cleavage activities, which were determined independently of the 
other, equal about 100% of total Bid cleavage. Generation oft-Bid, a critical point 
connecting extrinsic and intrinsic pathways, by at least two different protease families 
provides beneficial repetitive mechanisms to maximize cytochrome c release and 
apoptosis induction through mitochondria pathways. Thus, nsPEFs promote pro-apoptotic 
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signals that overcome resistances to apoptosis, which are present in most if not all 
cancers, thereby potentially abolishing the universal cancer hallmark of apoptosis evasion 
(122). 
By analyzing several different E4 cell responses to nsPEFs by flow cytometry, it 
was possible to establish several other characteristics for nsPEF-induced cell death. 
Under nsPEF conditions that eliminated >95% of E4 SCC, only 50% of cells exhibited 
cytochrome c release and decreases in A\|/m, while 75-80% of cells exhibited active 
caspases. Moreover, each of these responses showed different thresholds or sensitivities 
among themselves, with cytochrome c release as the least sensitive response. Sensitivities 
for plasma and inner mitochondria membrane permeability appeared to be similar, 
although plasma membrane reactions as determined by PI uptake and PS externalization 
were overall more responsive than inner mitochondria membrane as determined by 
decreases in A\|/m. These are most likely due to nanopore formation in the respective 
membranes. These results are consistent with an overall greater initial response from 
plasma membrane sensitivity leading to activation of extrinsic apoptosis mechanisms 
compared to intrinsic mechanisms from mitochondria membrane sensitivity. An extrinsic 
mechanism is also consistent with a greater response from extracellular calcium and a 
lesser response from intracellular calcium. 
The predominance of extrinsic mechanisms with greater effects on plasma 
membranes and from extracellular calcium-dependent responses compared to intrinsic 
mechanisms measured by decreases in A\|/m and intracellular calcium-dependent 
responses can possibly be explained by characteristics of electric fields pulses. Pulsed 
electric field requirements for intracellular membrane effects include a fast pulse rise 
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time, high electric fields, and a pulse duration that is shorter than the relaxation time of 
intracellular membrane, which is on the order of- 100 ns (104). While pulses used here 
have sufficient rise times and electric fields (<4 ns and 60 kV/cm, respectively), the 
relatively long 300 ns pulse duration may not be short enough to allow fully effective 
intracellular effects. While the mechanism(s) for caspase activation remains to be 
defined, nsPEF effects are due to membrane charging events. While PI uptake occurs in 
>95% of cells, and cytochrome c is released in about 50% of cells, caspases are activated 
in 75-80% of cells. This suggests that charging of the plasma membrane may be more 
closely tied to caspase activation than charging of intracellular membranes. This is 
consistent with caspase activation occurring before cytochrome c release, reminiscent of 
the type I cell extrinsic mechanism, and greater numbers of cells exhibiting PI uptake at 
lower electric fields than cells with decreased Av|/m. At the highest electric field tested 
(60 kV/cm), all of these nsPEF induced responses are coincident with cell death in >95% 
of cells indicating heterogeneous cell responses in nsPEF-induced cell death. Given that 
- 75-80% of cells express active caspases, caspase-associated cell death appears to be a 
predominant event. Thus, cell death occurs against different backgrounds of mitochondria 
responses in A\|/m, cytochrome c release and caspase activation. While decreases in A\|/m, 
caspase activation and cytochrome c release may all occur within given populations of 
cells, other cell populations may exhibit one or more of these, most notably through the 
cytochrome c-independent extrinsic pathway(s). Thus, nsPEF-induced apoptosis 
mechanisms are heterogeneous within E4 SCC populations as well as heterogeneous 
among cell types (101, 115). 
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Special consideration should be made for using PI uptake as a cell viability 
marker and phosphatidylserine externalization as an apoptosis marker in response to 
electric field stimulation. Using PI as a viability marker could be misleading given that 
electric fields have transient and reversible effects on membrane permeability. Some cells 
can survive after conventional electroporation as well as after sub-lethal nsPEF 
conditions (146). Thus, to avoid possible erroneous conclusions when evaluating effects 
of electric field on plasma membranes it is not advisable to use PI uptake as a viability 
marker. In the studies here, 300 ns pulse durations are long enough to allow plasma 
membrane pores to expand so they are large enough to include PI, which is on the order 
of about a nanometer. Nevertheless, the pulse durations are short and fast enough to 
induce intracellular membrane effects. Moreover, modeling evidence indicates that 
nsPEFs can ' 'pull" phosphatidylserine through nanopores (117, 147-150) acting as an 
apoptotic mimic that in the presence of macrophages was shown to cause phagocytosis of 
caspase-negative cells (151). Thus, to avoid possible erroneous conclusions, 
phosphatidylserine externalization should not be used as an apoptosis marker or used 
very cautiously when evaluating effects of electric fields on plasma membranes. 
Particularly, PI and Annexin-V should not be used alone as indicators for 
viability/necrosis and apoptosis, respectively, when evaluating effects of electric fields or 
other stimuli. In addition, defining apoptosis characteristic in vitro can be complicated by 
the presence of artifacts that are not present during apoptosis in vivo. In this study, events 
within the first 2 h were a primary focus to avoid or lessen these issues. While time 
courses for cell death are stimuli-dependent, nsPEF effects occur relatively rapidly in E4 
51 
cells. What can be discerned in this time fame, especially within the first hour(s), is 
reported in this study. 
There may be a case made for a unique type of nsPEF-induced cell death. Cell 
death initiated by nsPEFs can be differentiated from TNF-induced necroptosis, H2O2-
induced necrosis and anti-Fas-induced secondary necrosis (152) in that nsPEF, in contrast 
to cold exposure, did not exhibit ROS generation determined with CM-H2DCFDA and 
did not lead to hyperpolarization of A\j/m as the other stimuli-induced cell death did. 
Thus, E4 SCC mechanisms that protect against DNA and other damage from ROS are not 
expected to be effective in response to nsPEFs. Given that electric fields with nsPEF 
characteristics do not exist in nature, nsPEFs provide a distinct cell death stimulus, which 
could account for the heterogeneity of nsPEF-induced responses in E4 SCC. 
In E4 cells, new evidence is provided that nsPEFs act through multiple 
mechanisms to induce cell death at least in part due to apoptosis through extrinsic type I, 
extrinsic type II and/or intrinsic pathway(s). Based on several lines of evidence, the type I 
extrinsic pathway appears to be predominant among these. While calpain activation can 
be initiated by mobilization of calcium from intracellular and/or extracellular sources by 
nanopore formation, it remains to be determined how a presumed plasma membrane 
stimulus leads to caspase activation. The extrinsic pathway is activated by plasma 
membrane death receptors. It is possible that electric field interactions with the plasma 
membrane could activate these receptors either through nanopore formation or some 
other charging event that rearranges lipid bilayers. Alternatively, changes in membrane 
permeability could alter the intracellular milieu, such as apoptosis volume decrease (153), 
leading to caspase activation. Aside from caspase activation other mechanisms are likely 
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to contribute to nsPEF-induced cell death. Since necrosis induced by immediate plasma 
membrane rupture is not a significant cause of E4 SCC cell death, nsPEFs must set into 
motion events that are mediated by biological mechanisms in response to nsPEF-
mediated stresses that are at least in part programmed. 
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CHAPTER III 
NANOSECOND PULSED ELECTRIC FIELDS (NSPEFS) INDUCE APOPTOSIS 
VIA MITOCHONDRIAL INTRINSIC PATHWAY IN JURKAT CELLS 
ABSTRACT 
To determine whether nanosecond pulsed electric fields (nsPEFs) induced 
apoptosis through the extrinsic and/or intrinsic pathway we used human wild-type (WT) 
Jurkat cells and Jurkat clones that were deficient in either FADD (AFADD) or caspase-8 
(Acas-8). To determine molecular mechanisms of apoptosis, we show in all clones treated 
with nsPEFs evidences of apoptosis, including irreversible decreases in mitochondrial 
membrane potential (A\|/m), cytochrome c release, activation of caspases, H2AX 
phosphorylation and Bid cleavage. In contrast to Fas-mediated cell death (CH-11 
antibody), which only exhibited cell death in WT, nsPEFs induced cell death (>90%) 24 
hours post pulse in all clones with identical electric field dependence. In all three clones, 
A\|/m decrease was detected immediately (~ 1 min) after pulsing and was not blocked by 
caspase inhibitor z-VAD-fmk or calpain inhibitor z-LLY-fmk or by the absence of 
calcium or sodium. After 1.5-3 hour post pulse, cytochrome c release was observed but 
was not inhibited by z-VAD-fmk or z-LLY-fmk and calpepetin; Caspase-9 was activated 
before caspase-3/7 and caspase-8 was not significantly activated; H2AX phosphorylation 
was inhibited by caspase inhibitor z-VAD-fmk; and cleavage of Bid was partially 
blocked by calpain inhibitors (z-LLY-fmk and calpepetin). Taken together, these data 
suggest near immediate, direct effects of nsPEFs on cell membranes followed by calpain-
dependent- and caspase-dependent-mechanisms through intrinsic pathways involving 
cytochrome c release, presumed apoptosome-mediated caspase activation, calpain- and 
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caspase-mediated Bid cleavage and apoptosis-mediated DNA double strand breaks. 
These results demonstrate that apoptotic cell death induced by nsPEF was through the 
intrinsic pathway. 
INTRODUCTION 
Nanosecond pulsed electric fields (nsPEFs) are non-ionizing, high power pulses 
with pulse durations on the order of nanoseconds. Unlike conventional electroporation 
pulses, which permeabilize the plasma membrane to facilitate delivery and uptake of 
large molecules and drugs (154, 155), nsPEFs has been experimentally demonstrated to 
induce nanopores with sizes less than 1-1.5 nm in all cell membranes (139, 140). NsPEFs 
can manipulate intracellular structures and processes profoundly though supra-
electroporation of cell members. The intracellular effects induced by nsPEFs include 
phosphatidylserine (PS) translocation (150), calcium mobilization from intracellular and 
extracellular sources (108, 109), nuclear DNA disruption (156), propidium iodide (PI) 
uptake across the plasma membrane (157), and calcein uptake into subcellular granules 
(104). Recently, nsPEFs has been shown to be a novel technology to effectively induce 
nonthermal cell death by apoptosis both in vitro and in vivo (100, 101, 105, 114). 
Apoptosis, a form of programmed cell death (PCD), is an essential process for 
homeostasis maintenance and embryonic development. Deregulation of apoptosis 
mechanisms has been implicated in pathogenesis of many diseases such as cancer. 
Apoptosis is characterized by specific morphological and biochemical alterations of the 
cell, including phosphatidyl serine (PS) externalization, cell shrinkage, chromatin 
condensation, nucleosomal DNA fragmentation, and the disruption of mitochondrial 
membrane potential with plasma membrane blebbing and formation of apoptotic bodies 
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(1). The apoptotic cells are eventually recognized and phagocytosed by macrophages and 
neighboring cells. Although apoptosis can occur through caspase-independent 
mechanisms (10), activation of a cascade of highly homologous endopeptidases, 
caspases, lies in a pivotal position for induction and execution of apoptosis (8, 9). 
The apoptotic cascade can be initiated mainly through two distinct yet interrelated 
pathways: the extrinsic (death receptor) pathway and intrinsic (mitochondrial) pathway. 
The extrinsic pathway is activated through binding of death receptors (e.g. Fas/CD95, 
TNFa- or TRAIL) by a cognate ligand or an agonistic antibody (e.g. CH-11 for Fas), 
which induces multimerization of death receptors and recruitment of adaptor molecules 
(e.g. FADD and TRADD) and pro-caspase-8 to the receptor complex to form the death-
inducing signaling complex (DISC) (158, 159). Pro-caspase-8 is then activated by 
proteolysis within the DISC (160). In type I cells, caspase-8 directly cleaves downstream 
executioner pro-caspase-3. In type II cells, caspase-8 induces the cleavage of the BH3-
only protein Bid to generate truncated Bid (t-Bid), which in turn translocates to 
mitochondria and with Bax or Bak stimulates the release of cytochrome c from 
intermembrane space into cytosol (161). The intrinsic pathway is characterized by 
mitochondrial damage and subsequent cytochrome c release (162). In the presence of 
dATP/ATP, cytochrome c binds to Apaf-1 to assemble the "apoptosome", where pro-
caspase-9 is activated by proteolysis. Consequently, caspase-9 activates downstream 
executioner caspases and executes the final steps of apoptosis. 
The intrinsic pathway was reported to be critical for caspase cascade activation in 
Jurkat cells, classified as type II cells (24). Previous data suggested that it is difficult to 
identify the apoptosis signaling pathways induced by nsPEFs in Jurkat cells due to the 
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coincidence of caspase activation and cytochrome c release (101). In this context, to 
further understand the mechanisms of apoptosis induction by nsPEFs, we investigate the 
involvement oft-Bid, mitochondria, caspase activation and H2AX phosphorylation 
during nsPEF-induced apoptosis in Jurkat cells. It is herein shown that nsPEFs can induce 
apoptosis in caspase-8-deficient and FADD-deficient Jurkat cells. Furthermore, both 
caspase-dependent and caspase-independent calpain pathways are involved in the 
regulation of nsPEF-induced apoptosis. In addition, evidence is provided for the first time 
that nsPEFs induce apoptosis in Jurkat cells through the intrinsic pathway. 
MATERIALS AND METHODS 
Cell culture—Wild type Jurkat T-lymphocytes (clone A3) and mutant cell lines 
deficient for FADD (clone I 2.1) or caspase-8 (clone I 9.2) were purchased from ATCC 
(Manassas, VA). Clone A3 and I 9.2 were cultured in RPMI 1640 medium (ATCC) 
containing 10% fetal bovine serum (FBS) (Atlanta Biologist), 1% L-glutamine and 1% 
penicillin and streptomycin. Clone I 2.1 was maintained in RPMI 1640 medium (ATCC) 
supplemented with 15% FBS, 1% L-glutamine and 1% penicillin and streptomycin. All 
the cell lines were maintained in a humidified incubator with 5% C02 at 37°C. Use of the 
Jurkat cell line does not constitute human subjects research. 
Induction of cell death —Cells were resuspended in fresh culture medium at a 
density of 7.7x106 cells/ml. 130ul of cell suspension was placed in a 0.1-cm gap-width 
cuvette (Biosmith, San Diego, CA) and exposed to 60ns pulses ten times with electric 
field strength ranging from 0 to 60kV/cm. The Frank Reidy Research Center for 
Bioelectrics provides a course to present the safe use of high voltage pulse power 
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equipment. The authors have been trained in the safe use of this equipment. In some 
experiments, Jurkat clones were treated with CH-11, an agonistic anti-Fas antibody. 
Determination of cell viability 24 hour post pulse—Jurkat cells were seeded at 10 
cells per well in 96-well plates after pulsing. 24 hours after plating, cell viability was 
measured by CellTiter-Glo Luminescent Cell Viability Assay (Promega, Madison, WI), 
which determines viability by measuring ATP content of cells that is directly proportional 
to cell number. The luminescent signal was analyzed with a microplate luminometer 
(Gemini XPS, Molecular Devices, CA). 
Determination of Caspase-3/7, -8, and -9 (-like) activities—Caspase-3/7, -8, and -
9 (-like) catalytic activities were assayed using the Caspase-Glo-3/7,-8, -9 assay 
(Promega, Madison, WI). According to manufacturer's instruction, cells were placed in 
triplicate into 96-well plates at a density of 105 cells/well after pulsing. Plates were kept 
at room temperature for 30 min and 100(0.1 of Caspase-Glo-3/7, -8, and -9 reagents 
containing the selective luminogenic substrates z-DEVD, z-LETD, z-LEHD for caspase-
3/7, -8, -9 respectively, was then added into each well. Luminescence was read using a 
microplate luminometer (Gemini XPS, Molecular Devices, CA) after 1 hour incubation at 
room temperature. 
Flow Cytometry Analysis of H2AX phosphorylation—Cells were harvested at 
different time periods (1.5, 3, 6 hr) after nsPEFs treatment (60 kV/cm, 60 ns, 10 pulses) 
and were resuspended in fixation/permeabilization solution (BD Cytofix/Cytoperm™ kit, 
BD Biosciences) for 20 min at 4°C and after washing twice in lx BD Perm/Wash™ 
buffer, cells were then incubated with 1:100 diluted monoclonal anti-yH2AX (Serl39) 
(Cell Signaling Technology) for 1 hr at 37°C and followed by incubation with a 
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secondary Alexa 488-conjugated goat anti-rabbit IgG (1:200) for 45min at room 
temperature (Molecular Probes, Invitrogen). After washing twice in BD Perm/Wash 
buffer, the fluorescence of 10,000 cells was analyzed using a Becton Dickinson FacsAria 
flow cytometer (488nm, FL-1). 
Flow Cytometry Analysis of mitochondrial membrane potential 
(Ay/m)—Depolarization of the mitochondrial membrane potential was detected using a 
fluorescent lipophilic cation, tetramethylrhodamine ethyl ester (TMRE) 
(Immunochemistry Technologies LLC). Cells were preincubated with 200 nM TMRE in 
the presence or absence of 50 uM z-VAD-fmk, 50 uM z-LLY-fmk, 20 uM BAPTA-AM 
(intracellular calcium chelator) and 5 mM EGTA (extracellular calcium chelator) for 20 
min at 37°C. To determine A\|/m in the presence and absence of sodium, cells were 
resuspended in Tyrode's buffer with sodium (NaCl, 145 mM; KC1, 5 mM; 
MgS04-7H20, 1 mM; Na2HP04, 0.4 mM; HEPES, 5 mM; glucose, 6 mM; pH 7.4) and 
modified Tyrode's buffer with N-methyl-D-Glucamine (145 mM) substituted for sodium 
(N-Methyl-D-Glucamine), for 20 min in the presence of 200 nM TMRE. At the end of 
incubation, cells were resuspended in PBS, Tyrode's buffer, or modified Tyrode's buffer 
and exposed to ten 60 ns pulses with 0 and 60 kV/cm electric fields. Flow cytometric 
analysis was performed immediately (within 1 minute) after pulsing. In other experiments 
A\|/m was determined at various times after treatment with nsPEFs. A separate analysis 
included pulsing cells and then incubating with TMRE for 20 min before flow cytometric 
analysis. The average intensity of red fluorescence (10,000 cells) was analyzed on the 
FL-2 channel of a Becton Dickinson FacsAria flow cytometer. 
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Flow Cytometry Analysis of cytochrome c release—Cytochrome c was assessed 
using the Innocyte Flow Cytometric Cytochrome c Release assay (Calbiochem). At 0, 
1.5,3,6 hour post pulse, cells were permeabilized for 10 min on ice, fixed with 8% 
paraformaldehyde for 20 min at room temperature, washed with washing buffer 
andresuspended in blocking buffer. Cells were then incubated with primary antibody for 
lhour at 37°C and secondary antibody for 1 hour at room temperature. Cells (10,000) 
were analyzed by Becton Dickinson Facs Aria flow cytometer. 
Immunoblotting analysis—At specific time points after nsPEFs treatment, control 
and nsPEFs treated cells were collected and washed with cold PBS once. Cell were lysed 
in RIPA buffer (50mM Tris-HCL, 150mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 
0.1% SDS) (Boston BioProducts) for 30min at 4°C. The lysates were centrifuged at 
14,000 rpm for 20 min at 4°C, and the protein content in the supernatant was measured 
using BCA assay kit (Pierce). Equal amounts of protein (50ixg) were separated by SDS-
polyacrylamide gel electrophoresis, transferred to PVDF membranes and incubated with 
a primary antibody to Bid/t-Bid (Cell signaling Technology, MA) at a dilution of 1:1000, 
followed by IRDye680-conjugated secondary antibody (LI-COR Biosciences) in 
blocking buffer for 1 hour. Protein-antibody complexes conjugated with IRDye 680 were 
quantified on the Odyssey Infrared Imaging System (LI-COR Biosciences). P-Actin 
(1:1000; Cell signaling Technology) was used as a loading control. 
Statistical analysis—All experiments were performed at least three times 
independently in this study. All the data were expressed as mean ± standard error (S.E.). 
Statistical differences between control and treated groups were analyzed by a paired 
Student's t-test (two-tailed) with/) < 0.05 regarded as statistically significant. 
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RESULTS 
NsPEFs induce cell death in an electric field-dependent manner in Jurkat cells in 
vitro—To determine cell viability after nsPEF treatment, Jurkat clones were exposed to 
ten 60 ns pulses of 0-60 kV/cm electric field strength. Cell viability was measured by 
CellTiter Glo assay 24 hour post pulse. Results indicated that nsPEFs induced cell death 
in all clones with identical electric field dependence when determined 24 hours post 
pulse. Pulsing at 60 kV/cm resulted in <10% survival and an LD50 between 30 and 40 
kV/cm in all three clones. Thus, cell death in Jurkat clones treated with lethal nsPEF 
conditions was not dependent on the presence of FADD or caspase-8. As a comparison, 
agonistic anti-Fas antibody (CH-11) was used to treat all three Jurkat clones. Cell death 
was only found in wild type clone in a dose-dependent manner with the treatment of 50 
ng/ml anti-Fas antibody (CH-11). Caspase-8 or FADD deficient clones survived 
treatment with CH-11 antibody. These results indicate that the DISC is indispensable for 
anti-Fas antibody-triggered cell death in Jurkat cells. We also used the CH-11 with 
concentration higher 50 ng/ml to treat wild type clone, greater cell death response did not 
occur (data not show), which indicates maximum cell death effect can be reached by 
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FIGURE 8. Determination of nsPEFs- and Fas mAb (CH-ll)-induced 
cell death in Jurkat clones. A, NsPEFs induced cell death in all Jurkat 
clones in an electric field amplitude-dependent manner. Three Jurkat clones 
were pulsed ten times at 60 ns and electric field strengths between 0 and 60 
kV/cm. B, left panel: Fas mAb (CH-11) induced cell death in WT Jurkat 
clone in a dose-dependent manner. Right panel, all Jurkat clones were 
treated with 50 ng/ml CH-11. Cell viability was determined by CellTiter-
Glo luminescent cell viability assay 24 hour post pulse. Values from each 
point were normalized to control values. A, The values represent the mean ± 
SE (n=3). B, The value represents one experiment. *p < 0.05; ** p < 0.01. 
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NsPEFs induce coordinated decreases in mitochondrial membrane potential 
(Ay/m) and decreases in forward light scatter in Jurkat cells—To determine whether 
mitochondrial membrane potential (A\|/m) decreased after nsPEF treatment and whether 
A\)/m dissipation was a direct effect induced by nsPEFs, Jurkat WT clone A3 was 
preincubated with TMRE followed by exposure to ten 60 ns pulses at 60 kV/cm. Flow 
cytometry was performed within 1 minutes after pulsing. Results demonstrate that A\j/m 
decrease immediately upon nsPEF treatment. About 54% of cell population exhibited 
decreased A\|/m 1 min post pulse. As it was shown in Fig. 9, there was a time-dependent 
increase in the number of cells with a decreased A\|/m; 87% of cell population show 
dissipated A\|/m 1 hour post pulse. 
It was also of interest to determine whether caspases, calpain, or the absence of 
calcium affected A\|/m in response to nsPEFs. Jurkat clones were preincubated with z-
VAD-fmk, z-LLY-fmk, or EGTA/BAPTA-AM in growth media in the presence of 
TMRE. Fig. 10 shows histogram plots and Fig. 11 shows contour plots of flow cytometry 
experiments and Fig. 12 shows statistical comparisons of these results. Fig. 11 shows that 
there is no significant difference between pretreated cell population and non-pretreated 
population in response to nsPEFs, the A\|/m decrease is caspase- and calpain-independent. 
Furthermore, the absence of calcium had no significant effect on nsPEF-induced A\|/m 
disruption. Although there were no statistical difference in the presence and absence of 
calcium, the histogram plots differences in cell distribution in the absence of calcium. In 
the presence of calcium exposure to nsPEFs resulted in two populations of cells with 
greater than 10-fold difference in TMRE fluorescence. In the absence of calcium there is 
one broad population of cells instead of two distinct populations. Fig. 11 shows contour 
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plots for correlation of the decreased A\|/m as indicated by decreases in TMRE 
fluorescent intensity with a decrease in forward light scatter as a determinant of cell size. 
At 60 kV/cm decreases in forward light scatter was coincident with A\|/m disruption 
about 1 minute post pulse. 
It was also interesting to determine if the presence of sodium was required for 
dissipating A\|/m. Cells were, resuspended in Tyrode's buffer (with sodium) or modified 
Tyrode's buffer (N-methyl-D-Glucamine substituted for sodium), and incubated with 
TMRE to determine the sodium effect on A\|/m. The Av|/m dropped dramatically in 
modified Tyrode's buffer (with N-methyl-D-Glucamine) compared to cells in Tyrode's 
buffer. Most of the cell population (86.1 ±3.1%) showed decreased Av|/m within 1 minute 
post pulse. Compared to cells in growth media, forward light scatter of cells in Tyrode's 
buffer did not change dramatically; indicating Tyrode's buffer had minimal effects on 
cell size. Together, the cell responses suggest that nsPEF-induced drop in A\|/m is a direct 
effect that is independent of caspase and calpain activities or the presence of calcium and 
sodium. The decrease in A\|/m was correlated with decreased cell size occurred 
immediately after exposure to nsPEFs. 
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control 1 min 5 min 10 min 30min 45min 60min 
FIGURE 9. NsPEFs depolarizes the mitochondrial membrane potential (Av|/m) in a time 
dependent manner in Jurkat cells. Jurkat cells (wild type/clone A3) was preincubated with 
TMRE for 20 min. Cells were then pulsed with ten 60 ns pulses at 60 kV/cm. Percentages of 
cells with decreased A\|/m were determined by flow cytometry within 1 hour post pulse. Values 
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FIGURE 10. NsPEFs depolarizes the mitochondrial membrane potential (Av|/m) 
through caspase-, calpain-, sodium- and calcium-independent mechanisms. Jurkat 
cells (wild type/clone A3) was preincubated with TMRE for 20 min in the presence or 
absence of z-VAD-fmk (50 uM), z-LLY-fmk (50 uM) or BAPTA-AM (20 uM) and 
EGTA (5 mM). Cells were also preincubated with TMRE for 20 min in Tyrode's buffer 
with N-methyl-D-glucamine substituted for sodium. Cells were then pulsed with ten 60 
ns pulses at 60 kV/cm. Percentages of cells with decreased A\|/m were determined by 
flow cytometry 1 mm post pulse. Representative histograms are shown with cell counts 
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FIGURE 11 NsPEF-induced decrease in mitochondria membrane potential correlates with 
decreases in forward light scatter (cell size) in Jurkit cells. Jurkat cells (wild type/clone A3) 
was preincubated with TMRE for 20 min in the presence or absence of z-VAD-fmk (50 |iM), z-
LLY-fmk(50 uM) or BAPTA-AM (20 uM) and EGTA (5 mM) Cells were also preincubated 
with TMRE for 20 min in Tyrode's buffer with N-methyl-D-glucamine substituted for sodium 
Cells were then pulsed with ten 60 ns pulses at 60 kV/cm Percentages of cells with decreased 
A\|/m were determined by flow cytometry 1 min post pulse Representative contour plots are 
shown with forward light scatter (FSC-A) on the y-axis and TMRE fluorescence (PE-Texas Red-
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FIGURE 12. NsPEFs depolarizes the mitochondrial membrane potential (Avj/m) in Jurkat 
cells. Jurkat cells (wild type/clone A3) was preincubated with TMRE for 20 min in the 
presence or absence of z-VAD-fmk (50 uM), z-LLY-fmk (50 uM) or BAPTA-AM (20 uM) 
and EGTA (5 mM). Cells were also preincubated with TMRE for 20 min in Tyrode's buffer 
with N-methyl-D-glucamine substituted for sodium. Cells were then pulsed with ten 60 ns 
pulses at 60 kV/cm. Percentages of cells with decreased Av|/m were determined by flow 
cytometry 1 min post pulse. Values present the mean ± SE (n=3). **p<0.01; ***/?< 0.001. 
NsPEFs induce caspase-and calpain-independent cytochrome c release in a time-
dependent manner in Jurkat cells in vitro—The release of cytochrome c from 
mitochondria is a critical event in the type II extrinsic and the intrinsic apoptosis 
pathway. It initiates the assembly of the "apoptosome", which in turn actives pro-
caspase-9 and subsequent activation of other caspases (163). To determine whether 
cytochrome c was released and whether it depended on calpain or caspase, three Jurkat 
clones were preloaded with the caspase inhibitor z-VAD-fmk, or calpain inhibitors z-
LLY-fmk, PD 150606 and calpeptin. Cytochrome c release was determined within the 
first 6 hours post pulse using Innocyte flow cytometric cytochrome c release assay. Fig. 
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\3A shows cytochrome c release occurred between 1.5-3 hours post pulse in all three 
clones in a time dependent manner. Moreover, Fig. 13B shows that there is no significant 
difference among cytochrome c release in z-VAD-fmk-, z-LLY-fmk-, PD 150606-, 
calpeptin- treated cells and non-treated cells, indicating cytochrome c release is through 
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FIGURE 13. NsPEFs induce caspase-and calpain-independent cytochrome c release 
in Jurkat cells. A, Jurkat cells were preincubated with 50 uM general caspase inhibitor z-
VAD-fmk for 30 min followed by exposure to ten 60 ns pulses at 60 kV/cm and then 
analyzed by flow cytometry. B, Jurkat clones were preincubated with 10 uM calpeptin, 20 
uM PD 150606, 50 uM z-LLY-fmk, then cells were pulsed with ten 60 ns pulses at 60 
kV/cm. Cytochrome c release was evaluated by measuring percentage of cells that 
exhibited decreased levels of cytoplasmic cytochrome c at the indicated time point post 
pulse using the InnoCyte Flow Cytometric cytochrome c release assay. A, The graph 
represents the mean ± SE (n=3). B, The value represents one experimental result 
conducted at 3 hours post pulse. 
NsPEFs induce catalytic activities ofcaspsae-3/7, -9 in a time-dependent manner 
in Jurkat cells—To determine whether executioner and initiator caspases are activated 
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after nsPEF treatment, Jurkat clones were treated with ten 60 ns pulses at 60 kV/cm. 
Caspase-3/7, -8, -9 activities using caspase isozyme-selective substrates were determined 
by Caspase-Glo assay within 24 hours after nsPEF exposure. Results showed that nsPEFs 
increased the catalytic activities of caspases-3/7, -9 proteases in (A) wild type, (B) FADD 
deficient clone, and (C) caspase-8 deficient clone. Casapse-9 appeared to be activated 
first in all three clones. The peak of caspases-9 activation is at approximately 6 hours post 
pulse, whereas caspases-3 was activated dramatically at 9 hour post pulse in all three 
clones. Caspase-9 and caspase-3 activities were the greatest in the FADD deficient clone 
and the weakest in the caspase-8 deficient clone. Caspase-8 was only weakly activated in 
the wild-type (like all type II cells) and FADD mutant and, as expected, caspase-8 was 
essentially absent in the caspase-8 deficient mutant. 
NsPEFs induce Bid cleavage to t-Bid in Jurkat cells in vitro—To determine 
whether Bid is cleaved, we analyzed cells that were exposed to ten 60 ns pulses at 60 
kV/cm and then analyzed them by immunoblot analysis using the Odyssey imaging 
system to quantify the Bid and t-Bid levels at 0, 1.5, 3, 6 hours post pulse. Fig. 15̂ 4 
shows a typical immunoblot experiment of Bid and t-Bid in response to ten 60 ns pulses 
at 60 kV/cm. Fig. 15B shows quantitative ratio of t-Bid/Actin over a 6-hour time course. 
The results indicate that levels of Bid were decreased and t-Bid levels increased in all 
clones, including the two mutants. 
To determine the mechanisms by which Bid is cleaved, three Jurkat clones were 
pretreated with z-VAD-fmk (pan-caspase inhibitor), z-IETD-fmk (caspase-8 inhibitor), z-
AEVD-fmk (caspase-10 inhibitor), z-LLY-fmk (general calpain inhibitor), PD 150606 
(general calpain inhibitor), of calpeptin (general calpain inhibitor), followed by 
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immunoblot analysis oft-Bid level 3 and 6 hour post pulse. Fig. 16 indicates that both 
caspase and calpain contribute to Bid cleavage in nsPEF-induced cell death in Jurkat cells. 
In AFADD clones, Bid cleavage reached the peak with the highest expression level oft-
Bid compared to other two clones at 3 hours post pulse, the t-Bid level decreased at 6 
hours post pulse. In the other two clones, more significant t-Bid expression occurred at 6 












3 4.5 6 













• ' • 
7.5 
7.5 
FIGURE 14. NsPEFs increased the catalytic activity of caspase proteases of 
Jurkat cells. Cells were exposed to 10 pulses at 60 ns at 60kV/cm. The 
activities of caspase-3/7, -8, -9 were measured for various periods by Caspase-
Glo assay using DEVD-, LETD-, LEHD-aminoluciferin as substrates, 
respectively, in A, wild type (WT), B, FADD deficient clone (AFADD), C, 
caspase-8 deficient clone (Acas-8). Data represent the mean ± SE (n=3). * p < 
0.05; **p< 0.01. 
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FIGURE 15. NsPEFs induce Bid cleavage in a time-dependent manner in Jurkat 
cells. Jurkat cells were exposed with or without ten 60 ns pulse at 60 kV/cm. Whole cell 
extracts (50 ug protein) were separated by SDS-PAGE, transferred to PVDF membranes 
and probed with an anti-Bid antibody. A, Bid (22kDa), t-Bid (15kDa) and Actin (45kDa) 
levels were determined 0, 1.5, 3 and 6 hours post pulse by immunoblot analysis in a 
representative experiment as described in Material and Methods. Quantification was 
performed after normalizing t-Bid to Actin levels. B, Quantification of three experiments 
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FIGURE 16. NsPEFs induce caspase- and calpain-dependent Bid cleavage in 
Jurkat cells. Cells were pretreated for 30 min in the presence of calpeptin (20 
|iM), z-LLY-fmk (50 uM), z-VAD-fmk (50 uM), z-IETD-fmk (20 uM), or z-
AEVD-fmk (20 uM) prior to nsPEF administration. Cells were exposed to ten 60 
ns pulses at 60 kV/cm or sham treated. Cell lysates were prepared 3 hours post 
pulse as described in Material and Methods. Bid and t-Bid was quantified using 
Odyssey infrared imager and normalized to total Bid levels in control. Values 
represent one experiment. 
NsPEFs induce caspases-dependent H2AX phosphorylation in a time-dependent 
manner in Jurkat cells—DNA double-strand breaks (DSBs) are a type of DNA damage 
in which two single-strand nicks in the complementary double helix of DNA occurs 
simultaneously and sufficiently close to one another in locations, typically within 10-20 
base pairs (77). The rapid phosphorylation of H2AX in the position of Ser-139 to form 
yH2AX is an early event response to DSBs (78). To determine whether nsPEFs have 
direct effect on DSBs, yH2AX was determined in the first minutes and hours after 
treatment with nsPEFs. The presence of yH2AX was not observed until between 1.5 and 
2 hours post pulse. H2AX phosphorylation was detected in a time-dependent manner. To 
determine the caspase dependency of this event, three Jurkat clones were pretreated with 
pan-caspase inhibitor z-VAD-fmk, and then pulsed ten times at 60 ns, 60 kV/cm in the 
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presence of the inhibitor. yH2AX was determined 0, 1.5, 3 and 6 hours post pulse by flow 
cytometry using anti-yH2AX (Ser-139) antibody. H2AX was not activated until between 
1.5 and 3 hours post pulse. Fig. 17̂ 4 shows typical histogram results with H2AX 
fluorescence on the X-axis (FITC-A) and percentage of positive cells on the Y-axis. As 
H2AX is phosphorylated, increases in fluorescent results in a shift of the cell population 
to the right. Fig. \1B shows the combined results of three separate experiments with 
statistical analysis. In control clones, very few cells showed H2AX phosphorylation, 
whereas in treated cells, H2AX was significantly phosphorylated at 3-6 hours post pulse, 
and the phosphorylation was completely inhibited by the pan-caspase inhibitor z-VAD-
fmk. 
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FIGURE 17. NsPEFs induce H2AX phosphorylation in a time-dependent manner in Jurkat 
cells. Jurkat cells were exposed with or without ten 60 ns at 60kV/cm. yH2AX was detected with 
antibodies as described inMaterials and Methods 0, 1.5,3,6 hour post pulse. A, Representative 
histogram of yH2AX fluorescence (FITC-A) on the X-axis and cell count on the Y-axis. B, The 




The results presented here give us new insight into underlying mechanisms 
inducing apoptosis in response to nsPEFs in three Jurkat clones. Cell death induced by 
treatment with Fas antibody (CH-11) and nsPEFs appeared to be quite different in Jurkat 
clones. CH-11 can only induce cell death in wild type in a dose-dependent manner, 
whereas nsPEFs trigger cell demise in all three clones with identical electric-field 
dependence. This suggested that as in Jurkat cells, death receptor aggregation and 
subsequent DISC formation with Fas as death receptors and initiator caspase-8 were 
indispensable for CH-11-induced cell death in Jurkat cells. However, DISC formation is 
not required for cell death induced by nsPEFs. In E4 cells, the results reveal that nsPEF-
mediate cell death primarily though extrinsic-like pathways. However, in Jurkat clones, 
cell death can be induced without FADD and caspase-8, which indicate death receptors 
are likely not a mechanism for cell death induced by nsPEFs in Jurkat cells. 
According to the response upon CD95/Fas triggering, Jurkat cells are defined as 
type II cells (24). The mitochondria play a pivotal role in the apoptotic cell death of this 
type of cell. As described above, we showed that nsPEFs perturbed the A\|/m rapidly in 
Jurkat cells, indicating nsPEFs has direct effect on mitochondrial membranes. A wide 
variety of evidences demonstrated that nsPEFs create nanopores on intracellular organelle 
membranes, such as intracellular vesicles (104), endoplasmic reticulum (109), allowing 
calcium release from intracellular stores (108, 109). Modeling results also indicate that 
nsPEFs induce nanopores in cells (135-138). It is possible that nsPEFs porate the 
mitochondrial inner memberane, resulting in mitochondrial inner membrane 
depolarization immediate after pulsing. 
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Moreover, the drop in A\|/m occurs even in the presence of a general caspase 
inhibitor z-VAD-fmk, a general calpain inhibitor z-LLY-fmk, and calcium chelators 
BAPTA and EGTA. This strongly suggested A\|/m decrease is a primary effect. 
Furthermore, in the sodium free Tyrode's buffer, more cells showing decreased A\|/m 
compared to cells in the Tyrode's buffer without sodium, indicating sodium plays a role 
in maintenance of A\|/m. However, the increase in percentage of cells that exhibit 
decreased Aym indicates a time-dependent biological response that is initiated by 
nsPEFs. It has been shown previously that nsPEFs has differential effects on cells in S-
phase, which exhibited greater membrane integrity (146). That is a possible reason for 
different response time in terms of A\|/m disruption in the cell population. These studies 
are carried out with cell in log phase growth, so a significant number of cells are expected 
to be in S-phase. Another possibility is release of factors from cells that exhibited 
decreases in A\|/m. ATP can be released from cells and act on P2Y receptors, which are 
coupled to G-proteins leading to increases in intracellular IP3 and calcium. P2X receptors 
are purinergic ligand gated channels. Puringergic P2Y and P2X receptors can trigger 
specific chains of events which interact at the level of the individual elements both with 
each other and with the transduction mechanisms of other receptors, creating a huge 
diversity of the possible effects (164). 
Our results showed that nsPEFs induced a rapid A\|/m decrease; whereas 
cytochrome c was not released until 1.5-3 hours after nsPEF stimulation. NsPEFs induce 
cytochrome c release might through operating mPTP. It has been shown that nsPEFs can 
serves as a novel stimulus to open multiple types of voltage-gated Ca2+ channels in 
chromaffin cells (165). It is possible that nsPEFs can manipulate mPTP through the outer 
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membrane voltage-dependent anion channel (VDAC), ultimately open the mPTP. The 
opening of the mPTP leads to mitochondrial permeability transition (mPT), as a result, 
solutes (K+, Ma2+ and Ca2+ ions) and water enter the mitochondria, which results in 
mitochondrial matrix swelling, rupture of the outer membrane and hence loss of 
cytochrome c (166). In this study, the prompt A\j/m drop might lead to the cytochrome c 
leak out of the mitochondria within 1.5-3 hours after nsPEF stimulation in Jurkat cells. 
Alternatively, nsPEFs can induce cytochrome c release through Noxa/Puma (48, 49). 
Upon DNA damage or other stresses, p53 will be activated through various pathways. 
Noxa and Puma, which are direct transcriptional targets of p53, antagonize Bcl-2 function 
and work upstreatm of Bax and Bak to promote mtiochondrial depolarization and 
apoptosis (167). Our results indicated that nsPEFs can induce DNA double strand break 
as was shown by yH2AX, and H2AX phosphorylation was coincident with cytochrome c 
release. Noxa/Puma, transcribed following DNA damge-p53 induction, can interact with 
anti-apoptotic Bcl-2 family members Bcl-2 and Bcl-xl, leading to cytochrome c release 
(49). 
Cytochrome c is the key player in apoptosis execution. Once released, 
cytochrome c binds to Apaf-1 to form the "apoptosome", where pro-caspases-9 is 
activated. Activated caspase-9 then proteolytically process the downstream pro-caspases-
3. Our results showed that cytochrome c release was coincident with caspase activation. 
Caspase-9 activation occurred before caspase-3 was activated. Moreover, z-VAD-fmk, 
PD 150606, z-LLY-fmk, calpeptin failed to inhibit the nsPEF-induced release of 
cytochrome c from mitochondria in Jurkat clones, suggesting cytochrome c release was 
independent of caspase and calpain activities. Taking all these results into consideration, 
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we conclude that cytochrome c release, caspase-9 and -3 activation were through intrinsic 
pathway in nsPEF-induced cell death in Jurkat cells. 
We have shown previously that both calpain and caspase contributed to Bid 
cleavage in nsPEF-induced cell death pathways (100). It has been shown that several 
functionally distinct calpain inhibitors, such as calpeptin and PDl 50606 both blocked Bid 
cleavage (44). In this study, immunoblotting results showed that Bid cleavage was 
inhibited by several caspase inhibitors and calpain inhibitors. However, neither caspase 
nor calpain interfere with cytochrome c release. This suggests that both calpain and 
caspase might act downstream of cytochrome c release and Bid cleavage is downstream 
of caspase and calpain activation. 
It has been show previously that nsPEFs induce DNA damage in a wide variety of 
cells (107, 123, 130, 156). However, the causative mechanisms are still unclear. In 
B16fl0 melanoma, evidences suggested that initial DNA damage is caspase-independent. 
yH2AX and TUNEL positive cells were present before caspase activation after nsPEF 
treatment (114). Here, we defined the cause and effect relationships between active 
caspases and yH2AX in Jurkat cells in response to nsPEFs. In this study, we showed that 
H2AX was phosphorylated within 1.5-3 hours post pulse, which is coincident with 
cytochrome c release and caspase activation. With the use of z-VAD-fmk, almost all the 
yH2AX was inhibited within 6 hours, indicating H2AX phosphorylation is caspase-
dependent, and is downstream of caspase activities. It has been demonstrated that H2AX 
phosphorylation depends directly on caspase action and CAD activation. Caspase can 
active endonuclease CAD, release the DNase activity which causes DNA fragmentation 
in nuclei (14, 168), ICAD can inhibit yH2AX in Jurkat cells (169). 
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It is interesting that compared to the other clones; AFADD clone had greater 
caspase-9 and-3 activities, more Bid cleavage and greater yH2AX. Bid and H2AX are 
both caspase substrates, which suggests c-FLIP might compete with pro-caspase 8 first 
and then bind to FADD leading to cell survival. AFADD clone had stronger cell death 
effect in response to nsPEFs which might be the results of lacking the survival signal due 
to the deleted of the FADD adaptor molecule, or FADD might have inhibitory role in 
caspase activation and changes in caspase substrates. 
Cancer treatment often fails at the cellular levels due to mutation of cancer cells 
that cause evasion of apoptosis, multidrug resistance, and inhibition of signaling 
molecules (122, 170, 171). Molecular mechanisms escaping apoptotic elimination can 
also hinder localized physical therapies such as ionizing radiation as well as systemic 
pharmaceutical interventions (172, 173). NsPEFs have been shown to be a powerful 
technology for cancer treatment. It represents a local and drug-free treatment which leads 
to non-thermal cell death by apoptosis. The advantage of such a mechanism to the tissue 
would be that it removes damaged cells without the inflammation that necrosis would 
bring. Several studies have demonstrated that nsPEFs can cause murine malignant 
melanoma to complete self-destruct without recurrence (112-114, 124). The in vitro study 
indicated the most significant differences between B16fl0 melanoma cells and Jurkat 
cells is that cytochrome c was not released in melanoma cells in response to nsPEF-
induced cell death, suggesting that a Bid-independent extrinsic pathway was exclusively 
used to induce cell death (105). 
Absence of apoptosis molecules expression such as FADD and caspase-8 could 
confer multiple growth advantages on cancer cells, and is expected to contribute to 
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disease progression. As a consequence, the ability of bypassing cancer mutations 
represents a research field with potentially direct clinical applications. Our results here 
clearly showed that nsPEFs triggered cell death through the intrinsic pathway in Jurkat 
cells, bypassing DISC mutations, which provides advantage for treating cancers that 
abrogate apoptosis through irregularities in DISC mechanisms. These mechanisms 





NsPEFs induce programmed cell death with apoptosis characteristics in several 
cell lines in vitro, including mouse E4 SCC and three different human Jurkat clones. In 
all cell lines, cell death was >90% at the highest electric field. However, E4 and Jurkat 
cells exhibit very different nsPEFs sensitivities. While 60 kV/cm eliminated Jurkat cells 
coincident with apoptosis markers with 60 ns pulse, E4 cells required pulses with 
significantly longer pulse duration of 300 ns and 60 kV/cm. This is consistent with results 
from Stacey et al. (156) who demonstrated that cell growing in suspension, like Jurkat 
cell, was more sensitive to nsPEF than adherent cells, like E4 cells. In three Jurkat clones, 
the cell death induced by nsPEFs showed identical electric field-dependence. Thus cell 
death by nsPEFs was independent of the presence of caspase-8 and FADD and 
consequently independent of DISC formation. Multiple common apoptosis markers such 
as cell shrinkage, caspase activation, cytochrome c release, and A\|/m decrease were 
observed in both cell lines; DNA double strand breaks was detected in Jurkat clones. 
NsPEFs can activate multiple apoptosis pathways involving caspase- and calpain-
dependent and independent mechanisms, may or may not use cytochrome c release to 
initiate apoptosis signaling. Depending on the cell type and electric field strength, the cell 
responses to nsPEFs are distinct. In SCC, nsPEFs induce cell death primarily through 
extrinsic-like pathways with smaller contributions from intrinsic-like pathways. Cell 
death was coincident with PS externalization, caspase and calpain activation in the 
presence and absence of cytochrome c release, decreases in Bid and A\|/m without 
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apparent changes ROS levels or in Bcl-2 and Bcl-xl levels. In Jurkat cells, mitochondrial-
dependent intrinsic pathway is the primary cell death mechanism mediated by nsPEFs 
without involvement of DISC, although FADD and caspase-8 appear to contribute to 
several apoptosis markers. Cell death was accompanied with A\|/m dissipation, 
cytochrome c release, downstream initiator caspase-9 and executioner caspase-3 
activation, Bid cleavage, and DSBs. 
Calcium-dependent calpain activation occurred in both cell lines after nsPEF-
treatment. In SCC, Bid cleavage was caspase-dependent (55-60%) and calcium-
dependent (40-45%). Intracellular calcium and extracellular calcium was responsible for 
about 30% and 70% of calcium dependence for Bid cleavage, respectively. In Jurkat 
cells, although calpain inhibitor partially inhibits Bid cleavage as well, calpain inhibitors 
do not interfere with cytochrome c release, indicating that in contrast to activation 
through type II cell extrinsic pathway, Bid cleavage is downstream of cytochrome c 
release. This again suggests intrinsic mechanisms for apoptosis induction in Jurkat cells. 
These findings demonstrate that nsPEFs have profound effects on both plasma 
membranes and intracellular membranes, including ER, mitochondria, nucleus and DNA. 
NsPEFs also affect cell functions such as maintenance of plasma membrane potential, 
A\|/m, ATP production, calcium mobilization, protease and DNAse activities. In addition 
to these responses, nsPEFs have other advantages, such as the possibility to bypass 
common mutations in cancer (105), the absence of systemic side effects, and minimally 
invasive procedures with less scarring (112, 113). These features indicate that nsPEF can 
potentially serve as a therapeutic tool that can modulate cellular programmed cell death 
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mechanisms including apoptosis signaling to abolish evasion of apoptosis, an important 




The experimental data demonstrate that nsPEFs induce apoptosis primarily 
through intrinsic pathway in Jurkat cells. The decrease in A\|/m occurred immediately 
after nanopulsing, whereas cytochrome c was released within 1.5-3 hours post pulse. The 
mechanisms by which nsPEFs induce cytochrome c release in Jurkat cells remain to be 
determined. The Bcl-2 family members, either antiapoptotic or proapoptotic, regulate cell 
death by controlling mitochondrial membrane permeability during apoptosis. Bcl-2 is 
believed to prevent apoptosis by blocking cytochrome c release from mitochondria, 
whereas, oligomerization of Bax/Bak promote apoptosis by facilitating cytochrome c 
efflux (174). Conclusively indentify this mechanism requires analysis of Bcl-2 and 
Bax/Bak expression level. Immunoblotting with quantification analysis of Bcl-2 and 
Bax/Bak level can be conducted to indicate the role of Bcl-2 family proteins in nsPEF-
triggered apoptosis. If Bcl-2 family members play a role in cytochrome c release, a 
reduction in Bcl-2 expression accompanied with an increase in Bax/Bak level would be 
expected to occur. 
The cytochrome c release can be mediated through Noxa or Puma that are 
activated by nuclear p53 via its transcriptional activity (48, 49). Also, cytosolic or 
mitochondrial p53 can directly activate Bax/Bak via transcription-independent 
mechanisms. Puma and Noxa are proapoptotic BH3-only Bcl-2 family members, and are 
considered to indirectly induce mitochondrial outer membrane permeabilization (MOMP), 
causing the efflux of mitochondrial death-promoting proteins including cytochrome c. To 
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test the possibility that nsPEFs induce cytochrome c release indirectly by Noxa and (or) 
Puma, Jurkat cells will be treated with nsPEFs and then Noxa and Puma expression level 
will be examined by immunoblotting analysis over 6 hours post pulse. 
Increasing evidences suggest that ROS produced by mitochondria play an 
important role in stimulating cytochrome c release from cardiolipin. It is shown that ROS 
causes cardiolipin oxidation, which assists the detachment of cytochrome c and its release 
through the outer mitochondrial membrane into the cytosol. ROS may also be involved in 
promoting mPT by oxidating part of the mPT pore (175). Our previous data showed that 
ROS generation was not detected at any electric fields in both E4 and B16fl0 cells, those 
cells may have potent antioxidant activity that protect against DNA and other damage 
from ROS, are not expected to be effective in response to nsPEFs. However, information 
could be gained by investigating the changes in the levels of nsPEF-triggered ROS 
generation. Flow cytometric analysis using CM-H2DCFDA as a ROS indicator can be 
performed to identify ROS level after pulsing. If nsPEFs induce ROS in Jurkat cells and 
if E4 and B16fl0 cells protected against ROS detection, an increase in fluorescent 
intensity is anticipated. 
PS is translocated from the inner surface to the outer leaflet of the plasma 
membrane during apoptosis, which can be identified by phospholipid-binding protein 
Annexin V. PI is used to determine cell membrane integrity. The findings we obtained 
demonstrate that nsPEFs have effects on both plasma membranes and intracellular 
membranes. To determine the effect of nsPEFs on plasma membrane, flow cytometric 
analysis of cells double labeled with Annexin V and PI can be conducted. Based on the 
known effects of nsPEFs on plasma membrane nanoporation (140), results showing 
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increases in the percentage of Annexin V positive and (or) PI positive cell populations are 
anticipated. 
It is not advisable to use PI as a viability marker given that electric fields have 
transient and reversible effects on membrane permeability. Moreover, modeling evidence 
indicates that nsPEFs can "pull" PS through nanopores (117, 147, 149, 150). Thus, PS 
externalization should not be used as an apoptosis marker or used very cautiously when 
evaluating effects of electric fields on plasma membranes. 
It has been shown that nsPEFs cause caspase-dependent DSB as indicated by the 
presence of phosphorylated H2AX (yH2AX) (See Fig. 17). It has been shown that DNA 
damage may be directly caused by nsPEFs (114, 156). To determine whether nsPEFs 
induce more general DNA damage and endonucleolytic DNA fragmentation are induced 
by nsPEFs in Jurkat cells, terminal deoxynucleotidyl transferase (TdT)-mediated dUTP 
nick-end labeling (TUNEL) can be used. The strand breaks can be identified by TdT-
catalyzed attachment of fluorescein-dUTP to 3-OH' termini of cleaved DNA. If nsPEF-
induced DSB are direct effects, they should be seen at early times after treatment, an 
increase in the percentage of TUNEL positive cell population in nsPEF-treated cells 
should be seen in the first minutes after treatment. DNA laddering can be used to assess 
DNA fragmentation by agarose gel electrophoresis alternatively. Since H2AX 
phosphorylation was z-VAD-fmk-sensitive, significant DNA laddering may be observed 
after pulsing. 
In normal cells, caspase-dependent increases in CAD and decreases in ICAD is 
responsible for degrading the chromosomes into nucleosomal fragments as -180 base 
pair (bp) fragments during apoptosis (73). To identify the DNA damage mechanisms 
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induced by nsPEFs, immunoblotting with quantification analysis of ICAD level can be 
performed after pulsing. Since yH2AX has been shown previously, a time-dependent 
decrease in ICAD level with the occurrence of fragments pi 2 and p24 are expected to be 
observed in Jurkat cells. . 
Evidence has emerged that calcium-dependent calpain activation is responsible 
for Bid cleavage in Jurkat cells. To further define the mechanisms for apoptosis in 
response to nsPEFs, determination of calcium-dependent calpain activities can be done. 
Calpain activities can be measured by fluorometric assay using AC-LLY- AFC as 
substrate. Calcium can be quantified by flow cytometric analysis of fluo-4 (176). Based 
on results from E4 cells and the calpain-inhibitor sensitive responses in Jurkat cells, it is 
expected that time-dependent, calcium-dependent and calpain-inhibitor sensitive 
increases in calpain activities will be observed. Any activity resistant to these inhibitors 
would suggest other proteases such as cathepsins may be activated by nsPEFs. 
It has been demonstrated that mitochondria play a crucial role in nsPEF-induced 
apoptosis such that cytochrome c is released from mitochondria in both Jurkat cells and 
E4 cells. To further support these findings, Apaf-1 deficient Jurkat cells can be used to 
test the hypothesis. These cells will be treated with nsPEFs and then apoptosis markers, 
such as caspase-9 and -3 catalytic activities will be tested. Since nsPEFs are expected to 
act through the intrinsic pathway, the mutant Apaf-1 (AApaf-1) is supposed to block 
caspase-9 and downstream caspase-3 activation, in addition, inhibition of ICAD cleavage 
and H2AX phosphorylation. No significant caspase activities are expected to occur in 
Apaf-1 deficient Jurkat cells after the treatment of nsPEFs. 
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